Malignant neoplasm of pancreas, including Hilmo

C3_PANCREAS_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C25 Hospital discharge: ICD-9 — 157 Hospital discharge: ICD-8 — 157 Cause of death: ICD-10 — C25 Cause of death: ICD-9 — 157 Cause of death: ICD-8 — 157 Cancer registry: Topography ICD-O-3 — C25 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	3580
4. Check minimum number of events None	3580
5. Include endpoints None	3580
6. Filter based on genotype QC (FinnGen only)	3485

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_PANCREAS_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C25
HD_ICD_9	157
HD_ICD_8	157
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C25
COD_ICD_9	157
COD_ICD_8	157
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C25
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of pancreas, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3485	1480	2005
Unadjusted period prevalence (%)	0.75	0.52	0.92
Median age at first event (years)	71.18	70.89	71.39

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3580: Matched controls
35800

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D76

ICPC

Malignant neoplasm pancreas

1121.5

319.6

308

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

121.2

319.1

162

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

7.6

318.1

488

729

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

66.9

314.0

172

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

72.4

307.7

1148

232

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

120.1

307.7

948

107

JN4AD

NOMESCO Finland

Body CT examination

11.5

307.7

837

923

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

119.3

307.7

1370

185

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

173.7

307.7

197

TPX10

NOMESCO Finland

Implantation of vascular injection port

14.6

307.7

351

265

K83.1

ICD-10 Finland

Obstruction of bile duct

85.8

307.7

671

Z51.5

ICD-10 Finland

Palliative care

32.8

307.7

1446

725

JLC30

NOMESCO Finland

Pancreatoduodenectomy

1325.3

307.7

560

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

307.7

434

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

2117

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

307.7

683

A04AA02

ATC

granisetron; systemic, transdermal

1648.6

307.7

1051

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

307.7

660

JN4CD

NOMESCO Finland

Very extensive body CT

24.5

307.7

414

190

A04AA01

ATC

ondansetron; systemic, rectal

29.4

307.7

758

324

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

16.6

307.7

639

462

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

3624.4

307.7

340

K83.0

ICD-10 Finland

Cholangitis

17.0

307.7

292

186

A06AH03

ATC

naloxegol; oral

53.6

307.7

259

UJK02

NOMESCO Finland

ERCP

25.4

307.7

804

404

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

+∞

307.7

332

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

32.1

307.7

243

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

25.7

307.7

440

194

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

307.7

552

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

76.9

307.7

210

N02AA05

ATC

oxycodone; systemic

11.6

307.7

1937

3298

R4190

NOMESCO Finland

Nutritional therapy

18.7

307.7

399

239

JAH01

NOMESCO Finland

Laparoscopy

11.7

307.7

380

359

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

34.4

307.7

235

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

127.9

307.7

388

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

20.8

307.7

422

229

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

569

WX302

NOMESCO Finland

Thoracal epidural anesthesy

24.4

307.7

606

296

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

114.5

307.7

195

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3658.3

307.7

879

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

307.7

1556

JN4BD

NOMESCO Finland

Extensive body CT

10.9

307.7

718

805

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

17.2

307.7

384

249

WF002

NOMESCO Finland

Radical radiotherapy

70.6

307.7

181

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

107.5

307.7

593

A03FA01

ATC

metoclopramide; systemic, rectal

20.8

307.7

2024

2109

L03AA02

ATC

filgrastim; parenteral

179.1

307.7

250

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

50.2

307.7

600

143

JN3AD

NOMESCO Finland

Abdominal CT examination

5.8

307.7

864

1874

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

307.7

1969

WZC00

NOMESCO Finland

Treatment plan or consultation

4.0

307.7

1558

5727

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

794.2

307.7

598

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

26.6

307.7

303

124

H02AB02

ATC

dexamethasone; systemic

121.1

307.7

1276

163

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

307.7

706

L01BC06

ATC

capecitabine; oral

+∞

307.7

690

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

36.0

307.7

527

171

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

5.7

306.0

646

1328

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

20.7

306.0

235

121

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

698.6

266.4

260

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

6.3

265.8

489

878

WZC30

NOMESCO Finland

Teaching

4.4

260.6

784

2147

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

93.5

258.5

135

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1301.9

252.0

243

B01AB10

ATC

tinzaparin; parenteral

5.3

244.3

554

1203

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

242.5

230

L03AA13

ATC

pegfilgrastim; parenteral

817.4

236.3

230

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

8.6

234.2

314

398

R18

ICD-10 Finland

Ascites

12.5

229.4

231

197

A04AA55

ATC

palonosetron, combinations; systemic

+∞

223.3

212

WW500

NOMESCO Finland

Blood transfusion

9.8

220.4

263

287

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

23.9

219.7

158

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.9

218.7

776

2373

JMA10

NOMESCO Finland

Transabdominal total splenectomy

56.9

214.7

121

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

11.7

212.9

223

202

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

+∞

210.5

200

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

206.3

196

C61

ICD-10 Finland

Malignant neoplasm of prostate

314.2

204.6

206

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

31.4

203.7

133

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

203.1

193

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

32.9

202.0

130

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

13.5

194.9

186

145

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.2

190.1

584

1601

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

187.1

178

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

19.0

184.1

146

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.6

180.7

704

2271

R50.9

ICD-10 Finland

Fever, unspecified

3.4

173.1

771

2702

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

29.1

164.5

110

JLC10

NOMESCO Finland

Distal pancreatectomy

198.2

164.4

170

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

+∞

162.8

155

XX3DW

NOMESCO Finland

Time consuming IT work

5.2

161.9

358

752

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

20.0

157.9

122

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

154.3

147

8000/3-C25.0

ICD-O-3

Neoplasm, malignant of head of pancreas

+∞

154.3

147

A10AB05

ATC

insulin aspart; parenteral

3.7

149.3

528

1585

8500/3-C25.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of pancreas, NOS

+∞

149.0

142

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

1525.7

149.0

144

115

Kela drug reimbursment

Breast cancer

+∞

146.9

140

L02AE02

ATC

leuprorelin; implant, parenteral

53.1

145.2

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

737.5

145.1

142

C25

ICD-10 Finland

Malignant neoplasm of pancreas

1462.1

143.7

139

ZX120

NOMESCO Finland

Intravenous

4.0

142.6

449

1242

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

8.1

140.1

192

248

WF049

NOMESCO Finland

Radiotherapy of metastasis

472.3

138.2

137

JDE00

NOMESCO Finland

Gastrojejunostomy

355.6

137.7

138

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

69.6

137.6

B01AB05

ATC

enoxaparin; parenteral

2.4

133.6

1313

6850

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

40.4

130.0

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

21.9

129.3

116

Kela drug reimbursment

Prostate cancer

+∞

128.9

123

A10AE04

ATC

insulin glargine; parenteral

3.1

127.7

616

2234

WX402

NOMESCO Finland

General anaesthesia

2.9

124.4

727

2931

L02BG04

ATC

letrozole; oral

29.9

123.9

TPH07

NOMESCO Finland

Cathetrisation of artery

3.2

123.1

575

2044

B01AB04

ATC

dalteparin; parenteral

4.5

122.7

319

762

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

54.1

121.1

JAH00

NOMESCO Finland

Laparotomy

6.4

118.7

204

337

WX004

NOMESCO Finland

Patient-controlled sedation

23.5

117.9

A04AD12

ATC

aprepitant; systemic

586.7

115.7

114

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

115.2

110

SPAT1109

SPAT

Analgesia with portable analgesic pump

21.7

114.2

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

112.1

107

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

15.3

110.4

J01MA12

ATC

levofloxacin; systemic

2.5

107.7

873

4109

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

107.0

1354

7711

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

533.3

105.2

104

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

16.7

104.8

PJA12

NOMESCO Finland

Sentinel node biopsy

528.0

104.2

103

H01CB03

ATC

lanreotide; parenteral

522.7

103.1

102

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

18.2

102.0

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.5

101.7

762

3448

K86.1

ICD-10 Finland

Other chronic pancreatitis

9.8

100.2

117

123

A79

ICPC

Malignancy NOS

176.7

98.8

103

D70.82

ICD-10 Finland

Drug-induced neutropenia

22.2

97.7

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

8.3

95.8

128

160

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

50.8

95.2

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

94.8

905

4550

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

9.3

94.0

114

126

WX610

NOMESCO Finland

Patient controlled analgesia

20.1

92.4

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

921.7

92.3

A02BC02

ATC

pantoprazole; systemic

2.1

92.2

2513

18727

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.9

91.7

170

302

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

45.7

91.4

L01AX03

ATC

temozolomide; systemic

+∞

91.0

HAB40

NOMESCO Finland

Wedge excision of mammary gland

18.2

90.7

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

11.3

89.3

K86.8

ICD-10 Finland

Other specified diseases of pancreas

22.8

89.1

K85.8

ICD-10 Finland

Other acute pancreatitis

12.0

88.7

8500/3-C25.0

ICD-O-3

Infiltrating duct carcinoma, NOS, of head of pancreas

+∞

87.9

N02AX02

ATC

tramadol; systemic, rectal

2.0

87.6

1665

10825

PHN73

NOMESCO Finland

Reconstruction of superior mesenteric or portal vein

869.2

87.0

103

Kela drug reimbursment

Diabetes, insulin-treated

2.0

86.3

1347

8154

JLC11

NOMESCO Finland

Laparoscopic distal pancreatectomy

178.3

83.5

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

80.7

1215

7224

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

24.1

79.9

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

79.5

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

6.0

78.7

141

242

WF004

NOMESCO Finland

Palliative radiotherapy

785.3

78.7

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

77.4

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.9

76.4

238

646

H01CB02

ATC

octreotide; parenteral

136.3

75.2

ZX122

NOMESCO Finland

Intra-arterial

17.0

74.7

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

32.4

74.3

JL2AT

NOMESCO Finland

Cytology of pancreas with ultrasound guidance

722.7

72.4

ZX121

NOMESCO Finland

Central venous catheter

37.1

70.7

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.8

70.1

227

633

C25.7

ICD-10 Finland

Malignant neoplasm: Other parts of pancreas

+∞

70.0

191

Kela drug reimbursment

Erlotinib

+∞

70.0

8140/3-C25.2

ICD-O-3

Adenocarcinoma, NOS, of tail of pancreas

+∞

70.0

A06AD11

ATC

lactulose; oral

2.2

70.0

774

4070

WPB10

NOMESCO Finland

Making a convalescent care decision

32.5

69.7

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

22.5

69.5

8240/3-C25.9

ICD-O-3

Neuroendocrine tumor, NOS, of pancreas, NOS

+∞

69.0

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

13.6

68.2

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

28.5

66.8

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

65.9

833

4595

C24.1

ICD-10 Finland

Malignant neoplasm: Ampulla of Vater

+∞

65.8

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

65.8

XX2RW, ,

NOMESCO Finland

13.8

65.6

D13.7

ICD-10 Finland

Benign neoplasm: Endocrine pancreas

138.6

64.1

N02AA01

ATC

morphine; systemic, rectal

6.0

63.7

113

192

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

63.2

610

3027

ZX090

NOMESCO Finland

Other technic of radiotherapy

88.0

62.1

1CD01, ,

NOMESCO Finland

+∞

61.6

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

11.2

61.5

HAC20

NOMESCO Finland

Total mastectomy

132.4

61.0

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

+∞

60.6

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

25.0

59.6

WF003

NOMESCO Finland

Adjuvant radiotherapy

206.8

59.2

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

587.6

58.9

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

203.3

58.2

8010/3-C25.9

ICD-O-3

Carcinoma, NOS, of pancreas, NOS

+∞

57.4

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.9

57.4

173

458

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.3

57.2

150

358

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

57.0

742

4111

JLC40

NOMESCO Finland

Total pancreatoduodenectomy

285.9

55.4

8249/3-C25.9

ICD-O-3

Neuroendocrine tumor, grade 2 of pancreas, NOS

+∞

55.3

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

147.3

55.0

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

54.7

1033

6461

A98

ICPC

Health maint/preventive medicine

0.6

54.5

2468

28679

8140/3-C25.1

ICD-O-3

Adenocarcinoma, NOS, of body of pancreas

+∞

54.3

NK6AN

NOMESCO Finland

Total body bone isotope imaging

20.7

54.0

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

275.1

53.3

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

53.3

L02BA01

ATC

tamoxifen; oral

85.8

53.0

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

51.2

1570A

ICD-9 Finland

Malignant neoplasm of pancreas, Head of pancreas

+∞

51.2

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.6

50.9

175

507

R11

ICD-10 Finland

Nausea and vomiting

2.5

50.6

348

1483

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

16.1

50.4

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

50.1

8140/3-C24.1

ICD-O-3

Adenocarcinoma, NOS, of ampulla of Vater

+∞

50.1

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

50.1

Z31.5

ICD-10 Finland

Genetic counselling

4.4

49.7

127

297

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

14.8

49.4

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.5

49.2

178

533

E34.0

ICD-10 Finland

Carcinoid syndrome

131.9

48.9

A41.8

ICD-10 Finland

Other specified sepsis

4.4

48.3

124

291

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

78.4

48.0

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

48.0

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

474.0

47.4

WPA13

NOMESCO Finland

Palliative consultation

17.1

47.1

JDE01

NOMESCO Finland

Laparoscopic gastroenterostomy

+∞

47.0

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.7

46.7

110

241

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.7

46.0

264

1029

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

45.9

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

+∞

45.9

L01XE03

ATC

[U] erlotinib

+∞

45.9

Y77

ICPC

Malignant neoplasm prostate

124.2

45.9

N05BA06

ATC

lorazepam; systemic, sublingual

2.7

45.7

255

980

KCD02

NOMESCO Finland

Transurethral resection of bladder

9.1

45.1

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

44.9

L02BB03

ATC

bicalutamide; oral

+∞

44.9

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

443.1

44.3

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

72.3

44.1

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.6

43.8

150

433

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

43.8

1637

12171

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

43.8

C50.99

ICD-10 Finland

Breast, unspecified

432.8

43.3

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

42.8

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

42.8

JLD12

NOMESCO Finland

Endoscopic drainage of pancreatic pseudocyst

93.2

41.8

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

41.7

WVA20

NOMESCO Finland

Medicine administration

4.1

41.7

117

294

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

412.3

41.2

R93.3

ICD-10 Finland

Abnormal findings on diagnostic imaging of other parts of digestive tract

10.6

41.1

8000/3-C25.1

ICD-O-3

Neoplasm, malignant of body of pancreas

+∞

40.7

197

Kela drug reimbursment

Sunitinib

+∞

40.7

K86.3

ICD-10 Finland

Pseudocyst of pancreas

9.3

40.1

WX002

NOMESCO Finland

Sedation and analgesia

1.8

40.0

714

4332

ZX070

NOMESCO Finland

Intensity modified radiotherapy

207.3

39.9

TJA10

NOMESCO Finland

Laparocentesis

89.1

39.8

JFA65

NOMESCO Finland

Endoscopic insertion of ileum stent

+∞

39.7

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.8

39.5

188

JLA00

NOMESCO Finland

Exploration of pancreas

202.2

38.9

JDH35

NOMESCO Finland

Endoscopic insertion of duodenal stent

202.2

38.9

158

Kela drug reimbursment

Everolimus

+∞

38.6

WW200, ,

SPAT

0.4

38.0

249

5349

JKA20

NOMESCO Finland

Cholecystectomy

3.3

37.9

146

455

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

37.6

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

37.6

I81

ICD-10 Finland

Portal vein thrombosis

10.9

37.3

J01MA02

ATC

ciprofloxacin; systemic

1.6

37.0

1383

10156

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

192.0

36.8

A10BA02

ATC

metformin; oral

1.6

36.5

1197

8516

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.0

35.8

101

255

WX892

NOMESCO Finland

Monitored bed care

2.2

35.5

309

1453

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

35.5

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

35.5

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

35.5

HA1AA

NOMESCO Finland

X-ray mammography

3.6

35.4

118

335

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

13.3

34.8

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

96.0

34.8

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

124.6

34.7

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

34.7

463

2553

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

34.4

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

34.4

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

34.4

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.4

34.2

223

4823

JMA11

NOMESCO Finland

Laparoscopic total splenectomy

57.8

34.2

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

33.4

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

9.6

33.3

N05AD01

ATC

haloperidol; systemic

2.9

33.3

163

584

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

33.0

1049

7371

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.0

32.9

151

522

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

32.3

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.0

31.8

143

488

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

31.3

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

31.3

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

31.3

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.7

31.2

179

696

R4110

NOMESCO Finland

Physiotherapy

1.6

30.9

869

5911

K86.2

ICD-10 Finland

Cyst of pancreas

5.0

30.7

134

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.1

30.6

127

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

30.2

340

Kela drug reimbursment

Everolimus

+∞

30.2

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

30.2

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

30.2

T90

ICPC

Diabetes non-insulin dependent

1.6

30.1

939

6542

ZZR00

NOMESCO Finland

Flap of skin

7.2

29.7

C10AA07

ATC

rosuvastatin; oral

0.6

29.2

542

8416

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

29.2

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

29.2

E13

ICD-10 Finland

Other specified diabetes mellitus

11.6

29.2

N06DX01

ATC

memantine; oral

0.3

29.1

2641

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

8.9

28.9

T73

ICPC

Neoplasm endocrine other/unspecified

294.3

28.8

JLA10

NOMESCO Finland

Biopsy of pancreas

80.8

28.8

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

151.2

28.7

D77

ICPC

Malignant digestive neopl other/NOS

151.2

28.7

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.3

28.6

171

P20

ICPC

Memory disturbance

0.5

28.5

218

4466

A10AE05

ATC

insulin detemir; parenteral

2.3

28.5

232

1060

KA1FN

NOMESCO Finland

Isotope renography

9.3

28.3

T89

ICPC

Diabetes insulin dependent

2.8

28.2

141

511

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

64.5

27.9

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

146.2

27.7

J94.8

ICD-10 Finland

Other specified pleural conditions

3.9

27.5

211

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

8.6

27.5

K85

ICD-10 Finland

Acute pancreatitis

3.5

27.4

277

C25.3

ICD-10 Finland

Malignant neoplasm: Pancreatic duct

+∞

27.1

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

27.1

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

141.1

26.6

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

5.5

26.5

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.7

26.3

146

559

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.5

26.2

256

K31.5

ICD-10 Finland

Obstruction of duodenum

26.0

26.1

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

26.1

K56.7

ICD-10 Finland

Ileus, unspecified

3.6

26.1

238

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

262.5

25.7

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.2

25.6

105

340

A41.9

ICD-10 Finland

Sepsis, unspecified

2.5

25.1

159

649

8000/3-C25.2

ICD-O-3

Neoplasm, malignant of tail of pancreas

+∞

25.0

C24.02

ICD-10 Finland

Common bile duct

+∞

25.0

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

8.5

24.9

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

5.0

24.9

107

JLB28

NOMESCO Finland

Endoscopic internal drainage of pancreatic duct

26.4

24.8

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

251.9

24.7

C50

ICD-10 Finland

Malignant neoplasm of breast

251.9

24.7

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

251.9

24.7

L02BG03

ATC

anastrozole; oral

251.9

24.7

ZX112

NOMESCO Finland

Subcutaneous

5.8

24.4

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

24.3

391

2275

TPX15

NOMESCO Finland

Removal of vascular injection port

22.1

24.3

YJ1CD

NOMESCO Finland

Very extensive CT examination of abdomen for dose design of radiotherapy

+∞

24.0

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

24.0

322

Kela drug reimbursment

Sunitinib

+∞

24.0

JN6AD

NOMESCO Finland

CT of torso and neck

6.6

23.8

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.7

23.8

210

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

6.1

23.7

JLC00

NOMESCO Finland

Excision of lesion of pancreas

241.6

23.7

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

23.5

255

1303

M25.5

ICD-10 Finland

Pain in joint

0.6

23.2

424

6681

WGA11

NOMESCO Finland

Planning of pain management

9.1

23.0

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

22.9

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

22.9

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

22.9

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

22.9

L01XE10

ATC

[U] everolimus

+∞

22.9

M79.6

ICD-10 Finland

Pain in limb

0.6

22.8

718

9977

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.6

22.8

580

8442

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.0

22.7

162

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

231.4

22.6

X76

ICPC

Malignant neoplasm breast female

120.8

22.6

B03XA02

ATC

darbepoetin alfa; parenteral

3.4

22.5

242

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.3

22.5

2138

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

4.7

22.4

109

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.6

22.4

117

ZXE00

NOMESCO Finland

One hour or less

1.5

22.3

1139

8699

N05CF01

ATC

zopiclone; oral

1.5

22.3

1114

8473

JN4SR

NOMESCO Finland

Very extensive PET-CT of receptors in whole body

+∞

21.9

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

21.9

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

21.9

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

25.2

21.7

XF612

NOMESCO Finland

Measurement of central venous pressure

25.2

21.7

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

80.6

21.7

Z51.0

ICD-10 Finland

Radiotherapy session

221.3

21.6

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.4

21.3

221

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

4.3

21.3

126

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

5.2

21.2

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.6

21.2

127

505

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

7.0

21.2

E14.8

ICD-10 Finland

Unspecified diabetes mellitus, with unspecified complications

7.3

21.2

SPAT1053

SPAT

Memory test

0.5

21.1

268

4682

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

8.5

21.0

L01XE04

ATC

[U] sunitinib

+∞

20.8

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

20.8

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

20.8

L01CB01

ATC

etoposide; systemic

+∞

20.8

L01EG02

ATC

everolimus; oral

+∞

20.8

8249/3-C25.2

ICD-O-3

Neuroendocrine tumor, grade 2 of tail of pancreas

+∞

20.8

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

20.8

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.3

20.6

241

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

110.7

20.6

SPAT1262

SPAT

Handing over of treatment supplies

1.6

20.6

632

4340

WX882

NOMESCO Finland

High dependency care

2.8

20.5

104

380

C10AX09

ATC

ezetimibe; oral

0.5

20.3

217

4003

EB1VA, ,

NOMESCO Finland

0.3

20.1

2097

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

20.0

559

8015

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

19.9

1161

9047

Z3231

NOMESCO Finland

Registered nurse

1.5

19.8

823

6015

N02AA03

ATC

hydromorphone; systemic, rectal

36.0

19.8

D13

ICPC

Jaundice

36.0

19.8

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

19.8

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

19.8

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

19.8

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

19.8

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

19.8

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

19.8

172

807

C10AA05

ATC

atorvastatin; oral

0.7

19.7

1018

12971

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

201.1

19.6

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

201.1

19.6

C90.0

ICD-10 Finland

Multiple myeloma

201.1

19.6

UJK12

NOMESCO Finland

Peroral cholangioscopy

14.7

19.4

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

31.5

19.2

L15

ICPC

Knee symptom/complaint

0.6

19.2

338

5412

N06DA02

ATC

donepezil; oral

0.3

19.2

1994

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

7.0

19.1

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

0.7

18.8

863

11252

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

18.8

8246/3-C25.9

ICD-O-3

Neuroendocrine carcinoma, NOS, of pancreas, NOS

+∞

18.8

325

Kela drug reimbursment

Erlotinib

+∞

18.8

PHC71

NOMESCO Finland

Suture of mesenteric or portal vein

+∞

18.8

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

18.8

1579X

ICD-9 Finland

Malignant neoplasm of pancreas, Pancreas, part unspecified

+∞

18.8

2390A

ICD-9 Finland

Neoplasm of unspecified nature, Digestive system

8.1

18.8

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.3

18.7

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

38.6

18.5

JFC00

NOMESCO Finland

Entero-enterostomy

30.2

18.3

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

17.6

18.2

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.0

18.1

129

Z2446

NOMESCO Finland

Social worker

2.1

18.1

179

883

I50.9

ICD-10 Finland

Heart failure, unspecified

0.6

18.0

313

5035

SAA02

NOMESCO Finland

Basic examination of mouth

0.7

18.0

1214

14870

WZC15, ,

NOMESCO Finland

33.1

17.9

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

5.1

17.9

ZXD05

NOMESCO Finland

Urgent procedure

1.4

17.8

941

7174

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.6

17.7

509

7287

C24.0

ICD-10 Finland

Malignant neoplasm: Extrahepatic bile duct

+∞

17.7

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

17.7

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

66.9

17.7

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.7

17.7

635

8692

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

17.6

510

3449

JKD00

NOMESCO Finland

Anastomosis of gallbladder to jejunum

180.9

17.5

V03AF03

ATC

calcium folinate; systemic

180.9

17.5

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

180.9

17.5

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

180.9

17.5

JN7AN

NOMESCO Finland

Somatostatin receptor isotope imaging

180.9

17.5

D70.89

ICD-10 Finland

Neutropenic splenomegaly

5.0

17.3

D01

ICPC

Abdominal pain/cramps general

1.7

17.3

301

1789

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.4

17.2

116

489

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

14.8

17.1

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

3.2

17.1

217

SAA01

NOMESCO Finland

Simple examination of mouth

0.7

17.0

1437

17062

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

17.0

165

809

C10AC01

ATC

colestyramine; oral

2.7

17.0

349

8160/3-C24.0

ICD-O-3

Cholangiocarcinoma of extrahepatic bile duct

+∞

16.7

L01EX01

ATC

sunitinib; oral

+∞

16.7

C24.09

ICD-10 Finland

Biliary duct or passage NOS

+∞

16.7

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

4.8

16.6

SPAT1255

SPAT

Intravenous administration of medicine

1.8

16.6

238

1335

JN4DD

NOMESCO Finland

Scout CT scan of torso

90.5

16.6

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

4.2

16.5

107

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

170.8

16.5

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

16.1

294

1768

K75.0

ICD-10 Finland

Abscess of liver

12.8

16.1

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

3.3

16.1

189

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.6

16.1

SDA03

NOMESCO Finland

Periodontal treatment

0.7

16.1

578

7936

JFB30

NOMESCO Finland

Right hemicolectomy

5.3

16.1

SPAT1290

SPAT

Preparation of deceased person

16.8

16.1

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

0.7

15.9

532

7413

JFB00

NOMESCO Finland

Partial resection of small intestine

3.4

15.9

166

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

6.9

15.7

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

15.7

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

15.6

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

15.6

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

15.6

L02BX02

ATC

degarelix; parenteral

+∞

15.6

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

15.6

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

15.6

OAA41

NOMESCO Finland

Health check based on individual needs

+∞

15.6

8140/3-C24.0

ICD-O-3

Adenocarcinoma, NOS, of extrahepatic bile duct

+∞

15.6

WPA13, ,

SPAT

85.5

15.6

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

85.5

15.6

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.3

15.6

123

556

WX600

NOMESCO Finland

Single shot through catheter

5.6

15.5

WX704

NOMESCO Finland

Intubation

1.9

15.4

210

1159

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

4.6

15.4

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

16.1

15.2

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

31.8

14.8

JLB12

NOMESCO Finland

Transduodenal endoscopic incision of pancreatic duct orifice

31.8

14.8

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

56.9

14.8

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.0

14.7

151

756

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

14.7

316

RD210, ,

NOMESCO Finland

3.4

14.6

155

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

14.6

244

1432

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

14.6

1026

8155

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

14.6

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

14.6

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

14.6

1571A

ICD-9 Finland

Malignant neoplasm of pancreas, Body of pancreas

+∞

14.6

JN7SN

NOMESCO Finland

Somatostatin receptor SPECT

+∞

14.6

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

14.6

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

14.6

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

14.6

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

14.6

PHN72

NOMESCO Finland

Plastic repair of superior mesenteric or portal vein

+∞

14.6

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

14.6

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

14.6

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

14.6

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

14.6

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

14.6

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

14.6

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

14.6

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

14.6

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.4

14.5

151

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

150.6

14.5

128

Kela drug reimbursment

Cancers of female genital organs

150.6

14.5

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

10.9

14.5

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.1

14.4

WPA43, ,

SPAT

36.2

14.4

L13

ICPC

Hip symptom/complaint

0.6

14.3

279

4385

Z3226

NOMESCO Finland

Physiotherapist

1.5

14.2

531

3775

R4110, ,

SPAT

0.4

14.2

1710

SDA02

NOMESCO Finland

Periodontal treatment, brief

0.7

14.0

525

7184

R01AD58

ATC

fluticasone, combinations; nasal

0.6

14.0

229

3760

E16.10

ICD-10 Finland

Hyperinsulinism

30.1

13.9

EB4VA, ,

NOMESCO Finland

0.3

13.9

1363

D02

ICPC

Abdominal pain epigastric

1.9

13.8

167

886

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

5.6

13.8

D75

ICPC

Malignant neoplasm colon/rectum

23.9

13.8

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

13.7

333

4977

R83

ICPC

Respiratory infection other

0.6

13.7

205

3449

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

13.7

343

2238

N05BA04

ATC

oxazepam; oral

1.4

13.6

794

6114

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

5.1

13.6

D44.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified

75.4

13.6

Z01.2

ICD-10 Finland

Dental examination

0.7

13.6

718

9264

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.9

13.6

226

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

13.5

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

13.5

8000/3-C24.9

ICD-O-3

Neoplasm, malignant of billiary tract, NOS

+∞

13.5

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

13.5

8240/3-C25.2

ICD-O-3

Neuroendocrine tumor, NOS, of tail of pancreas

+∞

13.5

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

13.5

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

13.5

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

13.5

C26.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of digestive system

+∞

13.5

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

13.5

C23

ICD-10 Finland

Malignant neoplasm of gallbladder

+∞

13.5

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

13.5

8500/3-C25.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of body of pancreas

+∞

13.5

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

13.5

8500/3-C25.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of tail of pancreas

+∞

13.5

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

140.5

13.5

L02BG06

ATC

exemestane; oral

140.5

13.5

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

13.4

428

6046

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

3.7

13.3

116

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

0.6

13.3

231

3736

N05AX08

ATC

risperidone; systemic

0.5

13.2

113

2252

SFA10

NOMESCO Finland

One-surface restoration

0.7

13.1

1004

12266

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

13.1

135

677

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

15.1

13.1

UJD02

NOMESCO Finland

Gastroscopy

1.9

13.0

168

911

H25.1

ICD-10 Finland

Senile nuclear cataract

0.7

12.8

736

9388

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

12.7

344

5031

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

3.9

12.7

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

0.7

12.7

372

5348

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

12.3

12.6

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

70.1

12.6

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

70.1

12.6

8010/3-C25.0

ICD-O-3

Carcinoma, NOS, of head of pancreas

+∞

12.5

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

12.5

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

12.5

8480/3-C25.9

ICD-O-3

Mucinous adenocarcinoma of pancreas, NOS

+∞

12.5

L01BC04

ATC

carmofur; oral

+∞

12.5

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

12.5

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

12.5

8249/3-C25.1

ICD-O-3

Neuroendocrine tumor, grade 2 of body of pancreas

+∞

12.5

DAX08

NOMESCO Finland

Fitting of hearing aid

0.4

12.5

1309

D13.9

ICD-10 Finland

Benign neoplasm: Ill-defined sites within the digestive system

20.1

12.4

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

130.5

12.4

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

130.5

12.4

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

130.5

12.4

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

130.5

12.4

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.7

12.4

341

4969

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

0.3

12.4

1229

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

4.7

12.3

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.9

12.2

195

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

37.7

12.2

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

37.7

12.2

L03

ICPC

Low back symptom/complaint

0.7

12.2

422

5880

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

0.8

12.1

947

11568

ZXF10

NOMESCO Finland

Interruption caused by technical failure of equipment

26.8

12.0

N07BC02

ATC

methadone; systemic

11.1

12.0

K92.0

ICD-10 Finland

Haematemesis

2.2

12.0

438

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

5.4

11.8

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

14.7

11.8

WX100

NOMESCO Finland

Conjunctival surface anesthesia

0.6

11.7

211

3391

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.4

11.7

1470

Z2221

NOMESCO Finland

Medical doctor

1.4

11.7

725

5621

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

11.7

298

4419

JN1CM

NOMESCO Finland

Upper part of abdomen extensive MRI examination with 3 Tesla magnet

19.0

11.6

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

0.7

11.5

711

9004

WX320

NOMESCO Finland

Spinalanesthesy

0.7

11.5

419

5791

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

4.2

11.5

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

11.5

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

11.5

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

11.5

C24.01

ICD-10 Finland

Cystic duct

+∞

11.5

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

11.5

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

11.5

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

11.5

C24.00

ICD-10 Finland

Hepatic duct

+∞

11.5

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

11.5

SPAT1088

SPAT

Blood transfusion

5.0

11.5

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

5.0

11.5

R10.0

ICD-10 Finland

Acute abdomen

2.2

11.4

427

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

11.4

623

8038

A10AC01

ATC

insulin (human); parenteral

1.6

11.4

287

1875

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

35.1

11.3

P01AB01

ATC

metronidazole; oral, rectal

1.3

11.1

1062

8754

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.1

11.1

106

518

ZX050

NOMESCO Finland

Stereotactic radiotherapy

20.1

11.1

WPA44

NOMESCO Finland

Nursing home for palliative care

20.1

11.1

N06DA03

ATC

rivastigmine; oral, transdermal

0.4

11.1

1338

L08

ICPC

Shoulder symptom/complaint

0.7

11.1

346

4924

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

8.0

11.1

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.6

11.0

235

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

0.6

11.0

177

2928

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.8

11.0

196

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.0

10.9

117

597

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.4

10.9

1185

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

0.6

10.9

154

2635

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.8

10.9

175

1017

E87.6

ICD-10 Finland

Hypokalaemia

2.0

10.9

114

577

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

10.8

1374

11739

ZY010

NOMESCO Finland

Hospital outpatient

2.2

10.7

438

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.7

10.6

304

4404

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

0.6

10.6

145

2503

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

14.2

10.5

207

Kela drug reimbursment

Chronic arrhythmias

0.7

10.4

349

4908

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

110.3

10.4

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

110.3

10.4

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

110.3

10.4

L01EB02

ATC

erlotinib; oral

+∞

10.4

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

10.4

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

+∞

10.4

1572A

ICD-9 Finland

Malignant neoplasm of pancreas, Tail of pancreas

+∞

10.4

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

10.4

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

10.4

XW2BT

NOMESCO Finland

Other cytological test with X-ray guidance

+∞

10.4

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

10.4

9680/3-C25.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of pancreas, NOS

+∞

10.4

YX9AW, ,

NOMESCO Finland

+∞

10.4

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

10.4

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

10.4

K65.0

ICD-10 Finland

Acute peritonitis

3.0

10.4

147

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.0

10.4

147

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.4

10.3

1505

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

10.3

326

2236

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

12.1

10.3

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

12.1

10.3

XX1AD

NOMESCO Finland

Other CT-examination

32.6

10.3

SDA01

NOMESCO Finland

Periodontal treatment, very brief

0.7

10.3

368

5113

WZC00, ,

SPAT

0.5

10.3

1859

SPAT1110

SPAT

Measurement of pain intensity

3.7

10.2

I50.0

ICD-10 Finland

Congestive heart failure

0.6

10.2

153

2577

R03AC02

ATC

salbutamol; inhalant

0.8

10.2

1163

13619

JFF23

NOMESCO Finland

Transversostomy

7.5

10.2

K02.1

ICD-10 Finland

Caries of dentine

0.8

10.1

1093

12892

M70.6

ICD-10 Finland

Trochanteric bursitis

0.6

10.1

175

2841

A10AE06

ATC

insulin degludec; parenteral

2.1

10.1

483

TDA90, ,

SPAT

0.4

10.0

1067

D48.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Retroperitoneum

14.6

10.0

A21

ICPC

Risk factor for malignancy

40.2

10.0

ZYC01, ,

SPAT

0.5

9.9

1508

N03AX16

ATC

[U] pregabalin

1.3

9.9

658

5144

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.7

9.9

190

XX9TB

NOMESCO Finland

Complementary X-ray examination with contrast

16.7

9.9

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

16.7

9.9

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

2.9

9.8

157

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

26.1

9.8

TQW20

NOMESCO Finland

Tatoe

26.1

9.8

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

20.1

9.8

Z53.8

ICD-10 Finland

Procedure not carried out for other reasons

4.9

9.8

JJA20

NOMESCO Finland

Open biopsy of liver

10.6

9.8

R96

ICPC

Asthma

0.5

9.7

109

1992

F03

ICD-10 Finland

Unspecified dementia

0.5

9.7

1454

A10BH01

ATC

sitagliptin; oral

1.5

9.6

334

2335

B01AC04

ATC

clopidogrel; oral

0.7

9.6

381

5202

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

0.6

9.6

171

2758

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

9.6

532

6878

WX725

NOMESCO Finland

Noninvasive ventilation

1.8

9.6

133

740

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.4

9.6

277

H81

ICPC

Excessive ear wax

0.7

9.6

323

4538

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

7.1

9.5

OAB44, ,

SPAT

0.4

9.5

1194

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.8

9.4

780

9534

JJ2CT

NOMESCO Finland

Biopsy of liver with CT guidance

100.3

9.4

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

100.3

9.4

KFC10

NOMESCO Finland

Bilateral orchiectomy

100.3

9.4

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

100.3

9.4

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

100.3

9.4

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

100.3

9.4

G47.3

ICD-10 Finland

Sleep apnoea

0.7

9.4

364

4991

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

30.1

9.4

WPA41

NOMESCO Finland

Psychosocial conversational support in palliative care

30.1

9.4

BBA50

NOMESCO Finland

Total parathyroidectomy

17.6

9.4

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

9.4

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

9.4

6706

FHL

Pancreatic homeectomy (eg Whipple)

+∞

9.4

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

9.4

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

9.4

JLA20

NOMESCO Finland

Needle biopsy of pancreas

+∞

9.4

PHH32

NOMESCO Finland

Plastic repair of superior mesenteric or portal vein

+∞

9.4

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

9.4

1BC05, ,

NOMESCO Finland

+∞

9.4

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

9.4

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

9.4

WPA15, ,

SPAT

+∞

9.4

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

9.4

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

9.4

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

9.4

L02BB04

ATC

enzalutamide; oral

+∞

9.4

L02BX03

ATC

abiraterone; oral

+∞

9.4

8249/3-C25.0

ICD-O-3

Neuroendocrine tumor, grade 2 of head of pancreas

+∞

9.4

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

+∞

9.4

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

9.4

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

9.4

9061/3-C62.9

ICD-O-3

Seminoma, NOS, of testis, NOS

+∞

9.4

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

9.4

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

9.4

L02AE04

ATC

triptorelin; parenteral

+∞

9.4

H25.8

ICD-10 Finland

Other senile cataract

0.6

9.3

222

3346

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

0.8

9.3

859

10356

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

8.7

9.3

G03HA01

ATC

cyproterone; systemic

10.7

9.3

D19

ICPC

Teeth/gum symptom/complaint

0.7

9.2

376

5112

DFF00

NOMESCO Finland

Pure tone audiometry

0.6

9.2

132

2251

K03.64

ICD-10 Finland

Dental calculus supragingival

0.7

9.2

402

5400

Z96.1

ICD-10 Finland

Presence of intraocular lens

0.7

9.2

301

4256

KAD00

NOMESCO Finland

Partial nephrectomy

13.7

9.2

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

9.1

103

536

G04BD12

ATC

mirabegron; oral

0.6

9.1

173

2748

K81.0

ICD-10 Finland

Acute cholecystitis

2.1

9.1

373

L12

ICPC

Hand/finger symptom/complaint

0.6

9.1

202

3094

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.0

9.1

441

L02AE03

ATC

goserelin; implant

8.3

9.1

TKE10

NOMESCO Finland

Puncture of prostate

36.8

9.0

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

36.8

9.0

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

9.0

139

800

A02BC05

ATC

esomeprazole; systemic

1.3

8.9

1182

10087

KEB00

NOMESCO Finland

Biopsy of prostate

3.8

8.9

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

0.2

8.9

645

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.9

8.9

104

548

SPAT1269

SPAT

Other puncture and/or drainage

4.2

8.9

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

2.9

8.9

144

SFA20

NOMESCO Finland

Two-surface restoration

0.8

8.9

1099

12813

E14

ICD-10 Finland

Unspecified diabetes mellitus

8.0

8.8

H02

ICPC

Hearing complaint

0.7

8.8

248

3613

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.3

8.8

294

JX1XB

NOMESCO Finland

Other X-ray examination of alimentary tract with contrast

9.5

8.8

L17

ICPC

Foot/toe symptom/complaint

0.7

8.7

541

6892

D06

ICPC

Abdominal pain localized other

1.6

8.7

203

1302

F51.0

ICD-10 Finland

Nonorganic insomnia

0.6

8.7

140

2316

L90

ICPC

Osteoarthrosis of knee

0.5

8.7

1438

K31.0

ICD-10 Finland

Acute dilatation of stomach

14.0

8.7

HAB99

NOMESCO Finland

Other partial excision of mammary gland

4.3

8.6

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

0.2

8.6

615

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

0.8

8.6

669

8261

PJA10

NOMESCO Finland

Exploration of lymph nodes

4.6

8.6

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

2.4

8.6

247

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

8.6

105

563

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.7

8.5

170

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.0

8.5

411

BCA30

NOMESCO Finland

Unilateral adrenalectomy

27.6

8.5

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

27.6

8.5

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

27.6

8.5

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

20.1

8.5

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.6

8.4

105

1860

R74

ICPC

Upper respiratory infection acute

0.7

8.4

345

4686

S77

ICPC

Malignant neoplasm of skin

12.8

8.4

D82

ICPC

Teeth/gum disease

0.8

8.4

553

6984

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

7.9

8.3

D63.0

ICD-10 Finland

Anaemia in neoplastic disease

+∞

8.3

JL1CT

NOMESCO Finland

Biopsy of pancreas with CT guidance

+∞

8.3

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

8.3

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

8.3

C16.00

ICD-10 Finland

Cardia

+∞

8.3

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

8.3

C24.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of biliary tract

+∞

8.3

R17.0

ICD-10 Finland

Hyperbilirubinaemia with mention of jaundice, not elsewhere classified

+∞

8.3

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

8.3

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

8.3

C78.4

ICD-10 Finland

Secondary malignant neoplasm of small intestine

+∞

8.3

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

8.3

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

8.3

C62.11

ICD-10 Finland

Malignant tumor of the descending testicle, seminoma

+∞

8.3

HAC25

NOMESCO Finland

Radical mastectomy

+∞

8.3

JDK01, ,

NOMESCO Finland

+∞

8.3

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

8.3

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

8.3

X77

ICPC

Malignant neopl genital female other

+∞

8.3

YJ3VG

NOMESCO Finland

MRI examination of abdomen with high intesity magnet for dose design of radiotherapy

+∞

8.3

8000/3-C25.8

ICD-O-3

Neoplasm, malignant of overlapping lesion of pancreas

+∞

8.3

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

8.3

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

8.3

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

8.3

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

8.3

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

8.3

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

0.4

8.3

993

J01MA14

ATC

moxifloxacin; systemic

1.5

8.3

246

1666

JDA55

NOMESCO Finland

Endoscopic dilatation of stomach, pylorus or anastomosis of stomach

9.4

8.3

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

0.7

8.3

236

3428

SPAT1111

SPAT

Planning of analgesia

2.8

8.2

145

HAE99

NOMESCO Finland

Other reconstruction of breast

14.5

8.2

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

14.5

8.2

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

0.7

8.2

396

5239

EBA00

NOMESCO Finland

Extraction of tooth

0.8

8.1

640

7901

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

0.5

8.1

1548

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

0.6

8.1

140

2275

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.5

8.1

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

33.4

8.1

JDA12

NOMESCO Finland

Endoscopic insertion of gastric stent

33.4

8.1

D37.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Appendix

11.7

8.1

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.4

8.1

211

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

2.8

8.1

141

M01AH05

ATC

etoricoxib; oral

0.8

8.0

1315

14930

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

10.0

8.0

OAB43, ,

SPAT

0.6

8.0

132

2166

ZXE70

NOMESCO Finland

Moren than 15 and less than 18 hours

7.2

7.9

TQW99

NOMESCO Finland

Other minor procedure on skin

1.8

7.9

104

570

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

0.6

7.9

142

2286

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

0.6

7.9

138

2235

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

7.8

146

886

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

0.6

7.8

156

2447

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

4.1

7.8

ZXC96

NOMESCO Finland

Robot assisted procedure

3.8

7.8

AA1AD

NOMESCO Finland

CT of head and brain

0.8

7.8

630

7753

B01AF02

ATC

apixaban; oral

0.7

7.7

243

3465

JFB40

NOMESCO Finland

Resection of transverse colon

45.1

7.7

K76.9

ICD-10 Finland

Liver disease, unspecified

2.6

7.7

156

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

2.6

7.7

162

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.4

7.7

204

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.3

7.6

235

WZC30, ,

SPAT

0.4

7.6

1066

G04CA52

ATC

tamsulosin and dutasteride; systemic

0.7

7.6

204

3002

OAA67, ,

SPAT

0.5

7.6

1240

RD160, ,

NOMESCO Finland

10.0

7.5

WPA11

NOMESCO Finland

Developing a plan for palliative care

10.0

7.5

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

0.7

7.5

190

2826

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

3.7

7.5

R05

ICD-10 Finland

Cough

0.7

7.4

351

4668

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

7.4

510

3995

M05BA02

ATC

clodronic acid; systemic

80.3

7.4

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

80.3

7.4

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

80.3

7.4

PC2SC

NOMESCO Finland

Liver angiography with X-ray

80.3

7.4

JKC30

NOMESCO Finland

Partial excision of bile duct and anastomosis to jejunum

80.3

7.4

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

80.3

7.4

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

80.3

7.4

SFA30

NOMESCO Finland

Three-surface restoration

0.8

7.4

786

9373

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

7.4

1242

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

3.4

7.4

E13.7

ICD-10 Finland

Other specified diabetes mellitus, with multiple complications

7.6

7.4

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

7.4

523

4116

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

7.3

205

1373

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

7.3

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

7.3

C22.7

ICD-10 Finland

Malignant neoplasm: Other specified carcinomas of liver

+∞

7.3

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

7.3

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

7.3

Z515, C250,

ICD-10 Finland

+∞

7.3

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

7.3

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

7.3

KCC10

NOMESCO Finland

Cystoprostatectomy

+∞

7.3

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

+∞

7.3

WPA12

NOMESCO Finland

A meeting to support loved ones after the patient's death

+∞

7.3

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

7.3

8140/3-C17.0

ICD-O-3

Adenocarcinoma, NOS, of duodenum

+∞

7.3

18699

ICD-8 Finland

Malignant neoplasm of testis

+∞

7.3

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

7.3

302

Kela drug reimbursment

Interferon alfa

+∞

7.3

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

7.3

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

7.3

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

7.3

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

7.3

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

7.3

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

7.3

C85.0

ICD-10 Finland

Lymphosarcoma

+∞

7.3

1CD02, ,

NOMESCO Finland

+∞

7.3

WGA10

NOMESCO Finland

Measurement of pain intensity

+∞

7.3

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

7.3

189

Kela drug reimbursment

Imatinib

+∞

7.3

V03AH01

ATC

diazoxide; systemic

+∞

7.3

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

7.3

JLB35

NOMESCO Finland

Transduodenal endoscopic extraction of foreign body from pancreatic duct

15.8

7.2

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

15.8

7.2

L04AX03

ATC

methotrexate; systemic

0.6

7.2

106

1793

NG1AA, ,

SPAT

0.4

7.2

776

N06DA04

ATC

galantamine; oral

0.3

7.2

656

SPAT1122

SPAT

Ascites puncture

30.1

7.1

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

20.0

7.1

SCA01

NOMESCO Finland

Preventive oral health care, short

0.7

7.1

381

4967

R06AX27

ATC

desloratadine; oral

0.7

7.1

371

4854

Z51.88

ICD-10 Finland

Other specified medical care

2.1

7.0

284

L01

ICPC

Neck symptom/complaint

0.7

7.0

196

2857

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

3.3

7.0

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.4

6.9

183

I50.1

ICD-10 Finland

Left ventricular failure

0.6

6.9

1510

ZXC40

NOMESCO Finland

Use of ultrasound

5.5

6.9

A05AA02

ATC

ursodeoxycholic acid; oral

2.6

6.9

142

M17.1

ICD-10 Finland

Other primary gonarthrosis

0.8

6.8

460

5814

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

3.3

6.8

JK1AT

NOMESCO Finland

Cathetrisation of bile cyst with radiological guidance

10.9

6.8

R05

ICPC

Cough

0.7

6.8

398

5126

JWE00

NOMESCO Finland

Reoperation for deep haemorrhage in gastroenterological surgery

6.1

6.8

Q44.21

ICD-10 Finland

Atresia of extrahepatic bile ducts

40.1

6.8

JDH32

NOMESCO Finland

Endoscopic dilatation of duodenum

40.1

6.8

C20

ICD-10 Finland

Malignant neoplasm of rectum

40.1

6.8

WPA40

NOMESCO Finland

Individual-centered psychosocial intervention in palliative care

40.1

6.8

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

40.1

6.8

GD1AA, ,

SPAT

0.5

6.7

1448

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

0.8

6.7

1092

12478

R02

ICPC

Shortness of breath/dyspnoea

0.7

6.7

212

3022

UJF02

NOMESCO Finland

Peroral enteroscopy

3.5

6.7

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

2.6

6.7

144

A04AA03

ATC

tropisetron; systemic

22.6

6.7

WPA10, ,

SPAT

22.6

6.7

DFF15

NOMESCO Finland

Speech audiometry

0.5

6.7

1079

R42

ICD-10 Finland

Dizziness and giddiness

0.8

6.6

491

6129

2522

FHL

Removal of parathyroidism or multiple parathyroidism (including removal of adenoma or total removal)

12.3

6.6

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

12.3

6.6

K81.9

ICD-10 Finland

Cholecystitis, unspecified

2.4

6.5

188

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

6.5

191

1292

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

6.5

191

1293

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

6.5

128

790

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.6

6.5

102

1694

P70

ICPC

Dementia

0.3

6.5

651

JJB30

NOMESCO Finland

Excision of two segments of liver

70.0

6.4

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

70.0

6.4

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

70.0

6.4

XW2AT

NOMESCO Finland

Cytology of deep organ with ultrasound quidance

70.0

6.4

WPA42

NOMESCO Finland

Family-centered psychosocial intervention in palliative care

70.0

6.4

A07AA09

ATC

vancomycin; oral

2.3

6.4

196

N05AH04

ATC

quetiapine; oral

0.7

6.4

247

3399

ZZR10

NOMESCO Finland

Flap of skin and muscle

7.4

6.4

KMAK, ,

NOMESCO Finland

0.8

6.4

968

11154

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

14.3

6.4

C09CA06

ATC

candesartan; oral

0.8

6.4

435

5490

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

0.5

6.4

1283

J45.9

ICD-10 Finland

Asthma, unspecified

0.7

6.4

328

4307

WX290

NOMESCO Finland

Other blockage of nerve

0.8

6.3

699

8325

M01AC06

ATC

meloxicam; systemic, rectal

0.8

6.3

777

9148

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

8.2

6.3

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

0.6

6.3

142

2168

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

6.3

400

H25.0

ICD-10 Finland

Senile incipient cataract

0.6

6.3

1595

I48.2

ICD-10 Finland

Chronic atrial fibrillation

0.5

6.3

991

DHB00

NOMESCO Finland

Excision of lesion of external nose

5.9

6.3

XX4BW, ,

NOMESCO Finland

11.0

6.3

K82.2

ICD-10 Finland

Perforation of gallbladder

9.3

6.3

AXX01, ,

SPAT

0.4

6.3

655

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

0.7

6.3

162

2401

ZYC01

NOMESCO Finland

Remote contact by phone

1.6

6.3

124

767

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.8

6.3

473

K52.1

ICD-10 Finland

Toxic gastroenteritis and colitis

18.0

6.3

L03AA04, ,

ATC

18.0

6.3

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

6.3

8246/3-C25.2

ICD-O-3

Neuroendocrine carcinoma, NOS, of tail of pancreas

+∞

6.3

TAD04

NOMESCO Finland

Sympathetic block of ganglion coeliacum

+∞

6.3

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

6.3

WE100

NOMESCO Finland

Profylactic cytostatic therapy

+∞

6.3

198

Kela drug reimbursment

Sorafenib

+∞

6.3

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

6.3

WB131

NOMESCO Finland

Very demanding neoadjuvant cytostatic therapy

+∞

6.3

8480/3-C25.0

ICD-O-3

Mucinous adenocarcinoma of head of pancreas

+∞

6.3

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

6.3

KAC20

NOMESCO Finland

Nephroureterectomy

+∞

6.3

8000/3-C26.9

ICD-O-3

Neoplasm, malignant of gastrointestinal tract, NOS

+∞

6.3

C80.0

ICD-10 Finland

Malignant neoplasm, primary site unknown, so stated

+∞

6.3

L01XE01

ATC

[U] imatinib

+∞

6.3

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

+∞

6.3

8020/3-C25.9

ICD-O-3

Carcinoma, undifferentiated, NOS, of pancreas, NOS

+∞

6.3

KE002

NOMESCO Finland

Radical radiotherapy of prostata and seminal vesicles

+∞

6.3

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

6.3

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

6.3

JKD10

NOMESCO Finland

Anastomosis of bile duct to duodenum

+∞

6.3

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

6.3

C79.0

ICD-10 Finland

Secondary malignant neoplasm of kidney and renal pelvis

+∞

6.3

8130/3-C67.9

ICD-O-3

Papillary urothelial carcinoma of bladder, NOS

+∞

6.3

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

+∞

6.3

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

+∞

6.3

8550/3-C25.9

ICD-O-3

Acinar cell carcinoma of pancreas, NOS

+∞

6.3

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

6.3

C76.8

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites

+∞

6.3

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

6.3

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

+∞

6.3

C64.80

ICD-10 Finland

Wilms tumour

+∞

6.3

1CB02, ,

NOMESCO Finland

+∞

6.3

C16.09

ICD-10 Finland

Malignant tumor of cardiac or other unspecified carcinoma

+∞

6.3

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

6.3

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

6.3

8151/3-C25.9

ICD-O-3

Insulinoma, NOS, of pancreas, NOS

+∞

6.3

1733A

ICD-9 Finland

Other malignant neoplasm of skin, Skin of other and unspecified parts of face[KASVOJEN IHON SYÖPÄ,CA BASOCELLULARE]

+∞

6.3

C62.1

ICD-10 Finland

Malignant neoplasm: Descended testis

+∞

6.3

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

6.3

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

6.3

C01

ICD-10 Finland

Malignant neoplasm of base of tongue

+∞

6.3

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

6.3

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

+∞

6.3

1749X

ICD-9 Finland

Malignant neoplasm of female breast, Breast (female), unspecified

+∞

6.3

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

+∞

6.3

M19.0

ICD-10 Finland

Primary arthrosis of other joints

0.6

6.2

138

2113

JLB42

NOMESCO Finland

Transduodenal endoscopic dilatation of pancreatic duct

26.7

6.2

6672

FHL

Cholecocenterostomy

26.7

6.2

C01DA14

ATC

isosorbide mononitrate; oral

0.8

6.2

482

5983

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

3.7

6.2

C01AA05

ATC

digoxin; systemic

0.7

6.2

195

2781

K02.0

ICD-10 Finland

Caries limited to enamel

0.7

6.2

161

2382

I10

ICD-10 Finland

Essential (primary) hypertension

0.8

6.2

1865

20203

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

4.0

6.2

R5140

NOMESCO Finland

Monitoring the use of the aid

0.7

6.2

155

2310

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

0.6

6.1

1509

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

7.7

6.1

ZX100

NOMESCO Finland

Oral

2.5

6.1

139

JDC20

NOMESCO Finland

Partial gastrectomy and Roux-en-Y reconstruction

12.5

6.1

ZZA50

NOMESCO Finland

Full thickness skin graft

12.5

6.1

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.6

6.1

117

1847

A10AD05

ATC

insulin aspart; parenteral

1.8

6.0

428

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

848

2166

4.82

312.16

7.1

2.2

98.53

37.59

u/l

0.88

745

1807

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1114

1979

7.72

307.65

3.5

2.0

0.19

0.20

g/l

2.39

1057

1780

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1924

1415

28.23

307.65

5.7

1.4

62.29

2.76

ug/l

3.22

1793

1053

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

902

289

41.39

307.65

5.8

1.8

4985.99

23.36

u/ml

6.14

845

258

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1129

2584

5.92

307.65

5.2

2.2

38.74

8.12

umol/l

42.16

1061

2196

(3000570) Elastase.pancreatic [Mass/mass] in Stool

964

748

17.27

307.65

1.5

1.4

154.10

289.05

ug/g

41.83

577

456

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1190

513

34.25

307.65

6.4

1.8

13108.62

25.80

u/ml

1.85

1088

403

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

187

179.31

307.65

3.7

2.6

94.84

79.96

pmol/l

0.17

159

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1993

8440

4.07

307.65

5.6

2.3

91.00

60.47

u/l

1.58

1912

7694

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

411

130

35.59

307.65

1.3

—

(4035726) Immunohistochemistry procedure

616

646

11.31

307.65

1.4

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

633

113

67.84

307.65

4.5

1.8

15.56

4.56

nmol/l

0.70

627

105

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2440

12983

3.76

303.05

21.3

3.7

25.09

12.18

umol/l

32.78

2376

12075

(3024561) Albumin [Mass/volume] in Serum or Plasma

2169

11502

3.25

253.89

10.6

3.8

31.47

35.21

g/l

138.30

2099

10424

(3023368) Bacteria identified in Blood by Culture

1638

7692

3.08

231.54

6.4

3.8

—

(40768441) Liver Pathology biopsy report

175

21.10

230.83

1.0

1.4

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

204

270.36

201.14

3.1

3.7

741.88

637.75

u/l

—

185

(3022217) INR in Platelet poor plasma by Coagulation assay

2279

13945

2.75

179.41

13.5

19.7

1.29

1.39

inr

2.12

620

3823

(3010370) Gastrin [Moles/volume] in Serum or Plasma

107

42.39

178.23

2.6

1.3

32.10

25.13

pmol/l

0.51

(3033658) Prothrombin time (PT) actual/Normal

1295

6195

2.71

164.63

6.6

3.5

78.25

84.30

15.31

1274

6019

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1488

7643

2.62

163.44

6.0

2.6

64.17

36.59

u/l

13.68

1432

7143

(3044640) Blood type and Crossmatch panel - Blood

1456

7496

2.59

157.94

3.2

2.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

943

3973

2.86

151.52

3.3

2.4

0.81

0.82

mmol/l

1.65

900

3617

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1857

11223

2.36

135.47

3.5

2.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2128

13993

2.28

122.39

22.1

6.0

4.53

4.41

e9/l

1.16

1901

11919

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1116

5728

2.38

114.54

3.0

2.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1025

5140

2.39

110.26

7.7

2.2

2.49

2.45

mmol/l

21.54

975

4358

(3002256) Pathology report gross observation

496

1786

3.06

102.84

1.5

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1464

8708

2.15

102.53

8.3

2.1

2.32

2.35

mmol/l

12.42

1372

7212

(3042936) Bacteria identified in Isolate by Culture

803

3724

2.49

101.67

2.1

2.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

177

322

5.73

93.12

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

714

3519

2.29

76.50

3.5

5.2

0.97

1.04

mmol/l

6.07

676

3190

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

332

1120

3.17

76.15

2.3

1.7

1.87

1.77

ug/l

0.06

303

955

(40768804) Tissue Pathology biopsy report

1268

7789

1.97

75.68

2.6

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

463

1909

2.64

73.19

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2202

16360

1.90

72.11

7.6

4.3

7.89

6.89

mmol/l

49.00

2123

15259

(3023183) Ammonium ion [Moles/volume] in Plasma

210

553

3.97

70.31

1.7

2.5

36.50

35.05

umol/l

0.24

188

489

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1936

13913

1.85

69.24

8.5

5.6

1.20

1.21

mmol/l

16.41

1639

11728

(3003694) ABO and Rh group [Type] in Blood

1011

5965

1.97

66.16

1.4

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2119

26074

0.54

65.86

4.0

4.8

1.35

1.44

mmol/l

16.65

1853

23592

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1779

12591

1.82

65.51

7.7

5.2

1.19

1.21

mmol/l

17.78

1688

11176

(3014007) Fractional oxyhemoglobin in Arterial blood

423

1760

2.59

65.30

8.2

8.0

94.80

93.37

6.34

423

1752

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2151

26318

0.54

64.83

4.1

4.8

4.34

4.49

mmol/l

8.44

1896

23979

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2236

27038

0.54

64.44

4.5

5.5

2.51

2.61

mmol/l

5.43

1965

24528

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

276

920

3.17

64.35

2.4

3.0

0.31

0.34

u/ml

0.76

143

549

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

848

4750

2.03

64.06

2.0

1.8

—

(40758558) Short blood count panel - Blood

994

5899

1.95

63.52

17.3

4.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

155

353

4.54

62.80

1.8

1.7

0.77

0.96

g/l

0.96

114

272

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

196

542

3.77

61.15

1.6

1.4

0.69

0.81

nmol/l

1.83

179

444

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2534

20278

1.85

59.16

23.1

5.3

178.30

76.46

u/l

120.89

2469

18643

(3002582) Erythrocytes [#/volume] in Urine

1251

8163

1.82

58.45

3.2

3.1

37.30

72.44

e6/l

1.79

992

6221

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

132

280

4.86

58.31

1.3

1.20

1.46

nmol/l

1.62

118

247

(3002173) Hemoglobin [Mass/volume] in Arterial blood

554

2734

2.21

57.82

8.5

6.9

114.66

121.80

g/l

15.02

542

2660

(3018677) aPTT in Platelet poor plasma by Coagulation assay

779

4376

2.00

57.62

2.1

1.9

30.41

30.13

0.52

764

4234

(3030467) Casts [#/volume] in Urine by Automated count

1150

7463

1.80

53.74

3.2

3.0

0.66

0.47

e6/l

1.78

916

5657

(3023487) Leukocytes [#/volume] in Peritoneal fluid

9.03

51.98

1.4

2.9

7622.88

678.56

e6/l

0.61

(3016502) Oxygen saturation in Arterial blood

581

3046

2.08

51.46

8.2

6.5

96.65

95.05

8.92

566

2922

(3018418) pH of Serum or Plasma

1213

8087

1.76

51.11

5.5

3.2

7.40

0.45

268

1392

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2085

25224

0.58

50.78

3.8

4.3

1.36

1.28

mmol/l

4.64

1809

22579

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

621

3358

2.03

50.47

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

617

3351

2.02

49.45

1.9

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

338

1448

2.47

48.54

10.0

8.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

194

623

3.24

47.95

2.1

1.5

165.61

25.55

u/ml

4.57

186

587

(3003396) Base excess in Arterial blood by calculation

608

3340

1.99

46.97

8.1

6.3

1.02

1.27

mmol/l

0.93

523

2597

(3026782) Osmolality of Urine

880

5453

1.81

46.88

2.9

2.8

541.93

543.56

mosm/kgh2o

0.08

796

4589

(4281824) Cell count and differential, peritoneal fluid

127

6.26

45.90

1.3

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

607

3366

1.97

45.52

8.1

6.2

13.95

11.47

kpa

21.16

590

3187

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

607

3367

1.97

45.48

8.1

6.2

5.07

5.04

kpa

0.31

588

3193

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

370

1709

2.30

44.72

1.6

1.5

—

(36304419) Bacteria [Presence] in Urine

1078

7176

1.72

44.35

3.1

3.0

—

(3000991) Gas panel - Venous blood

455

2307

2.11

43.57

7.2

7.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

479

2490

2.07

42.89

6.4

5.9

1.46

1.44

mmol/l

0.22

472

2413

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

12.95

42.59

1.3

2.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

653

3792

1.88

42.36

2.1

2.7

19.46

22.14

4.45

557

3154

(3018095) Leukocytes [#/volume] in Urine

1330

9450

1.65

42.23

3.6

3.5

71.47

113.96

e6/l

2.04

1023

6692

(3004789) Transferrin [Mass/volume] in Serum or Plasma

682

4042

1.85

41.38

2.1

2.6

2.22

2.28

g/l

1.80

647

3682

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2054

24516

0.62

40.84

4.2

4.6

2.07

2.09

mu/l

0.13

1799

21953

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

8.36

39.83

1.3

2.8

13887.93

37786.52

e6/l

0.33

(3022948) Iron [Moles/volume] in Serum or Plasma

720

4416

1.79

38.75

2.1

2.5

10.52

12.56

umol/l

11.45

693

4037

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2282

26484

0.62

38.71

5.0

5.1

6.69

6.09

mmol/l

42.76

2043

23685

(3033799) Differential panel - Peritoneal fluid

8.20

38.45

1.4

1.9

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

192

724

2.75

35.60

1.9

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

119

344

3.54

34.72

5.8

6.0

11.75

12.31

mg/l

0.63

106

312

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1946

15631

1.54

33.81

5.2

3.0

214.74

49.92

u/l

68.81

1847

14108

(3021447) Carbon dioxide [Partial pressure] in Venous blood

501

2868

1.87

33.36

3.3

3.4

5.64

5.85

kpa

5.37

486

2764

(3002032) Base excess in Venous blood by calculation

499

2860

1.87

33.08

3.3

3.4

2.06

2.04

mmol/l

0.03

422

2400

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

164

593

2.85

32.91

2.1

2.2

3.14

3.48

g/l

2.52

158

563

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

669

4191

1.73

32.87

2.9

2.8

3.12

2.42

e6/l

0.82

356

2295

(3027923) C peptide [Moles/volume] in Serum or Plasma

154

4.82

32.50

1.3

0.92

1.22

nmol/l

2.11

112

(3044007) Cell count panel - Peritoneal fluid

7.94

32.37

1.2

2.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

347

1773

2.06

32.15

1.9

1.7

—

(3012544) pH of Venous blood

511

2976

1.84

32.13

3.4

—

7.38

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

121

375

3.30

31.68

1.0

1.1

19.79

527.61

iu/ml

0.56

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

440

7311

0.55

30.61

1.6

1.43

1.33

mmol/l

1.03

386

6053

(3000850) Epithelial cells [#/volume] in Urine

847

5743

1.62

30.48

2.6

2.5

6.96

4.74

e6/l

3.47

786

5080

(3020779) Urea [Moles/volume] in Serum or Plasma

444

2525

1.87

30.00

4.1

6.6

8.80

11.41

mmol/l

10.73

419

2373

(3000963) Hemoglobin [Mass/volume] in Blood

2629

29106

0.64

29.00

49.1

21.0

121.47

135.30

g/l

307.65

2575

28454

(3007461) Platelets [#/volume] in Blood

2628

29093

0.64

28.90

48.8

20.8

254.32

241.21

e9/l

13.39

2546

28073

(3026361) Erythrocytes [#/volume] in Blood

2629

29100

0.64

28.86

48.8

20.9

4.09

4.46

e12/l

216.81

2537

27950

(3035941) MCH [Entitic mass]

2629

29099

0.64

28.84

48.6

20.8

30.22

30.47

10.40

2572

28440

(3024731) MCV [Entitic volume]

2629

29097

0.64

28.79

48.6

20.8

91.36

91.62

2.10

2573

28436

(3010813) Leukocytes [#/volume] in Blood

2630

29098

0.64

28.62

48.7

20.8

7.51

6.83

e9/l

35.41

2536

27947

(3009542) Hematocrit [Volume Fraction] of Blood

2629

29075

0.64

28.30

49.0

20.9

36.28

40.11

62.30

2390

26529

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

104

323

3.29

27.17

2.4

5.3

2693.62

498.66

iu/ml

—

(3024354) Oxygen [Partial pressure] in Venous blood

417

2397

1.84

27.10

2.9

3.0

4.39

4.48

kpa

0.40

403

2297

(40768795) Lymph node Pathology biopsy report

8.99

26.82

1.3

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1651

19886

0.68

26.41

3.6

3.8

15.02

pmol/l

0.02

1452

17697

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

281

1443

2.03

25.54

2.4

2.6

0.70

0.65

1.54

281

1435

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

684

4585

1.61

25.20

2.8

2.6

1.47

1.28

e6/l

0.65

370

2677

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

314

3.21

25.01

1.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1482

11740

1.45

24.49

5.8

5.6

—

(3019069) Monocytes/100 leukocytes in Blood

1491

11825

1.45

24.48

5.6

5.8

8.63

8.85

1.25

1415

10828

(3016650) Hepatitis A virus Ab [Presence] in Serum

300

3.23

24.18

1.1

1.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

353

1996

1.85

24.08

8.8

6.6

24.37

24.48

mmol/l

0.20

338

1903

(3006504) Eosinophils/100 leukocytes in Blood

1479

11763

1.44

23.67

5.4

2.44

2.99

18.51

1401

10758

(3031040) Bacteria [#/volume] in Urine by Automated count

2103

17829

1.44

23.64

4.7

4.6

262.34

2541.84

e6/l

3.45

304

(3002030) Lymphocytes/100 leukocytes in Blood

1509

12054

1.44

23.54

5.6

22.45

26.53

33.12

1434

11079

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2268

25583

0.69

23.47

7.8

6.5

44.94

40.97

mmol/mol

45.24

2091

23318

(3004119) Hemoglobin [Mass/volume] in Venous blood

345

1953

1.85

23.43

3.2

3.1

120.30

129.80

g/l

12.94

338

1902

(40768797) Stomach Pathology biopsy report

551

3602

1.63

22.25

1.3

1.2

—

(3022096) Basophils/100 leukocytes in Blood

1432

11413

1.42

22.22

5.4

5.5

0.59

0.67

7.09

1356

10426

(3017143) Hepatitis C virus Ab [Presence] in Serum

320

1815

1.84

21.55

1.3

1.5

—

(3018010) Neutrophils/100 leukocytes in Blood

1479

11924

1.41

21.18

5.4

61.38

58.32

14.56

1403

10955

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

332

1920

1.80

20.97

1.3

1.5

—

(3020891) Body temperature

243

1275

1.97

20.74

5.5

4.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

136

569

2.45

20.43

2.3

2.1

235.94

192.55

5.19

124

541

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

130

536

2.48

20.16

1.3

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

120

4.21

19.05

1.1

—

(4062490) Immunoglobulin typing, IgG

219

3.24

18.17

1.6

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

316

2.83

17.99

2.4

2.9

1.71

1.30

0.67

264

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

428

2768

1.62

17.83

3.8

2.7

257.46

238.57

u/l

1.18

410

2543

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

236

1290

1.89

17.82

7.5

4.3

1.69

1.63

0.39

221

1210

(3024139) IgG subclass 3 [Mass/volume] in Serum

217

3.22

17.76

1.6

1.4

0.41

g/l

0.01

158

(3028192) IgG subclass 2 [Mass/volume] in Serum

217

3.22

17.76

1.6

1.4

3.10

3.03

g/l

0.14

158

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

121

513

2.41

17.69

1.3

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

359

2226

1.68

17.64

5.5

3.0

1.22

1.23

mmol/l

1.19

339

1881

(3027135) IgG subclass 1 [Mass/volume] in Serum

217

3.17

17.10

1.6

1.4

6.86

7.05

g/l

0.16

158

(3001604) Monocytes [#/volume] in Blood

1526

12667

1.36

17.05

5.3

5.2

0.64

0.62

e9/l

1.50

1276

10782

(3006315) Basophils [#/volume] in Blood

1531

12723

1.36

16.95

5.3

5.2

0.04

e9/l

1.79

1279

10834

(3007930) Methemoglobin/Hemoglobin.total in Blood

230

1269

1.87

16.87

7.6

4.3

0.89

0.87

0.26

216

1191

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

16.68

1.1

0.0

—

(3019060) Gas panel - Arterial blood

337

2089

1.68

16.55

6.5

4.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

239

1350

1.83

16.27

2.9

3.7

24.40

24.22

mmol/l

0.37

233

1306

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2598

28151

0.72

16.13

26.1

9.3

40.15

25.22

u/l

68.83

2534

26736

(3019198) Lymphocytes [#/volume] in Blood

1551

12986

1.34

16.04

5.5

5.3

1.64

1.81

e9/l

8.98

1334

11267

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

169

856

2.02

15.95

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

379

2.55

15.85

1.3

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

272

1616

1.74

15.60

3.6

3.0

24.89

25.21

mmol/l

0.68

262

1557

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

181

3.24

15.17

1.1

1.2

10.56

9.48

mmol/l

0.67

170

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

719

9406

0.71

15.12

4.0

3.8

21.49

24.41

5.86

342

4613

(3023103) Potassium [Moles/volume] in Serum or Plasma

2615

28231

0.73

15.00

38.2

17.5

3.95

4.00

mmol/l

17.88

2554

27322

(3017181) Myelocytes/100 leukocytes in Blood

320

2008

1.65

14.96

2.7

3.7

1.11

0.87

0.96

166

523

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

4.69

14.92

3.1

2.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

11.33

14.74

1.3

1.1

—

(3036489) Thrombin time

163

841

1.98

14.63

2.0

1.8

23.14

21.10

2.79

152

751

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

113

3.84

14.56

1.1

—

(40768800) Prostate Pathology biopsy report

152

3.39

14.36

1.2

1.1

—

(3013115) Eosinophils [#/volume] in Blood

1554

13155

1.32

14.34

5.5

5.4

0.18

0.21

e9/l

6.78

1320

11332

(3019550) Sodium [Moles/volume] in Serum or Plasma

2615

28171

0.73

14.13

38.2

17.4

137.99

139.76

mmol/l

143.17

2555

27310

(3033705) Calcium.ionized [Moles/volume] in Venous blood

413

2.39

14.12

2.9

2.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

113

3.75

13.78

1.1

—

(3026008) Bacteria identified in Urine by Culture

1083

8744

1.34

13.73

3.0

3.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2260

24819

0.76

13.56

34.1

13.2

80.37

73.86

ml/min/173m2

41.33

2018

19942

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

738

9474

0.72

13.51

1.9

2.2

185.03

222.32

u/l

0.72

677

8794

(3012501) Base excess in Blood by calculation

127

617

2.10

13.46

5.4

4.6

2.77

2.74

mmol/l

0.04

409

(3007566) Smooth muscle Ab [Titer] in Serum

123

594

2.11

13.24

1.2

91.82

96.59

titre

0.06

(1761868) Lipid panel - Serum or Plasma

595

7880

0.71

13.07

3.1

3.3

—

(40761511) CBC panel - Blood by Automated count

2517

27181

0.75

12.94

29.7

14.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

200

2.93

12.86

1.8

1.4

—

(3039000) Anion gap in Blood

128

641

2.03

12.53

10.3

5.9

10.91

11.40

mmol/l

1.11

117

574

(3018572) Chloride [Moles/volume] in Blood

128

641

2.03

12.53

10.3

6.0

105.72

104.83

mmol/l

1.30

117

574

(3047181) Lactate [Moles/volume] in Blood

167

916

1.86

12.52

9.0

5.4

1.52

1.32

mmol/l

1.84

150

808

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

343

2.42

12.45

1.2

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

343

2.42

12.45

1.2

1.3

—

(3022475) Manganese [Moles/volume] in Blood

26.77

12.03

1.2

1.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

262

4009

0.63

11.87

1.2

6.77

15.35

u/ml

1.72

1456

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

247

2.62

11.52

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

332

2.38

11.43

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

334

2.37

11.28

1.3

1.5

34.57

27.55

g/l

3.18

291

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

961

11620

0.76

11.13

4.3

3.9

2.60

2.15

ug/l

1.38

814

10341

(3010421) pH of Blood

136

726

1.91

11.12

5.3

4.5

7.42

0.69

126

649

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

401

2829

1.47

11.06

5.1

3.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

249

1584

1.61

11.02

2.1

2.2

9.92

10.87

g/l

3.98

215

1426

(3021879) Hepatitis B virus core Ab [Presence] in Serum

183

1084

1.73

10.64

1.3

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

291

1936

1.55

10.63

2.7

3.7

0.18

0.08

1.52

140

453

(3023199) Leukocytes [#/volume] in Pleural fluid

303

2.37

10.38

1.2

1.5

2500.65

1458.47

e6/l

0.73

221

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

291

4234

0.66

10.35

1.2

1.3

36.05

41.37

iu/ml

0.34

1312

(3002179) Metamyelocytes/100 leukocytes in Blood

279

1850

1.55

10.34

2.6

3.5

0.74

0.65

0.23

138

460

(3051651) Icteric interference index of Serum or Plasma

127

3.17

10.27

5.2

3.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

493

6494

0.72

10.10

2.9

2.7

0.84

0.73

ug/l

0.62

340

4482

(40768793) Breast Pathology biopsy report

105

3.36

9.84

1.3

1.1

—

(3025159) Blasts/100 leukocytes in Blood

276

1848

1.53

9.79

2.7

3.8

0.10

0.09

126

375

(3019977) pH of Arterial blood

170

2.79

9.64

3.4

2.2

7.43

0.14

(3045788) Cell count panel - Pleural fluid

228

2.52

9.60

1.3

1.5

—

(40761536) Microorganisms panel - Urine sediment

299

2046

1.50

9.58

3.7

4.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

271

2.39

9.55

1.3

1.5

64139.47

58953.35

e6/l

0.04

162

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

395

2.13

9.39

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

188

1174

1.63

9.00

2.0

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

917

0.35

8.81

1.6

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

255

3678

0.67

8.61

3.8

5.0

32.75

33.18

0.23

156

2408

(3036481) Cortisol [Moles/volume] in Serum or Plasma

302

2117

1.47

8.59

2.6

1.8

419.45

365.02

nmol/l

3.52

283

1884

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

185

2.56

8.23

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

185

2.56

8.23

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

185

2.56

8.23

1.2

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

252

2.32

8.22

1.3

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

252

2.32

8.22

1.3

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

356

2.10

8.19

1.3

—

(3003338) MCHC [Mass/volume]

1984

21628

0.81

8.17

44.2

18.8

330.24

331.98

g/l

14.88

1949

21394

(3025941) Bacteria identified in Stool by Culture

197

1284

1.57

7.92

1.4

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

7.76

7.86

1.8

2.4

1.18

1.29

mmol/l

0.04

(3038177) Helicobacter pylori Ab [Presence] in Serum

316

2.14

7.82

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

197

2.46

7.73

1.4

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

318

2.13

7.70

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

172

1095

1.60

7.65

2.0

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

140

847

1.68

7.62

4.6

4.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

612

7534

0.77

7.52

2.9

2.5

3405.31

6502.35

umol/l

1.14

508

6371

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1417

0.52

7.47

1.8

1.9

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

880

7394

1.25

7.37

2.1

2.3

3.11

2.98

mg/l

0.74

772

6203

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

154

2.62

7.36

1.3

1.5

—

(40768806) Pleura Pathology biopsy report

229

2.29

7.19

1.4

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.68

7.18

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

249

2.23

7.13

2.9

3.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

309

2.09

7.07

1.3

—

(3021589) Normoblasts [#/volume] in Blood

1267

11171

1.21

6.51

18.3

8.6

0.00

e9/l

0.67

1009

9023

(3011648) Oxygen content in Venous blood

208

2.28

6.46

1.6

1.9

12.04

10.92

1.09

208

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1455

0.56

6.46

1.2

1.3

17.14

63.38

au/ml

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.07

6.46

1.5

2.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

426

1.87

6.42

4.0

3.5

60.11

58.91

0.34

426

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

718

5981

1.25

6.38

3.9

4.1

201.77

500.03

ng/l

1.81

583

5089

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

3.00

6.22

1.7

1.4

3.61

4.11

mg/l

0.36

(3024928) Oxygen saturation in Venous blood

104

617

1.71

6.16

2.3

2.9

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

127

2.61

6.12

1.4

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

287

2.04

6.05

1.1

1.80

1.53

g/l

2.46

244

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

128

2.59

6.03

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

107

646

1.68

5.95

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

107

646

1.68

5.95

1.4

1.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

153

2.43

5.94

2.9

1.9

17.52

16.04

nmol/l

0.51

132

(3016273) Islet cell 512 Ab [Units/volume] in Serum

11.14

5.79

1.0

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

2072

22188

0.84

5.78

42.7

16.4

15.38

15.35

0.13

2046

21646

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

306

1.98

5.78

1.1

1.4

109.82

112.32

u/ml

0.09

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

149

2.43

5.78

1.3

1.2

—

(3012441) Differential panel - Pleural fluid

252

2.08

5.75

1.3

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

100

1617

0.61

5.74

2.2

2.4

9.65

23.79

au/ml

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

357

1.89

5.69

1.1

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

303

1.96

5.59

1.6

1.3

—

nmol/l

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

304

1.96

5.54

1.6

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

383

1.84

5.49

1.3

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

178

2.26

5.48

3.7

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

594

1.67

5.41

2.4

2.5

14.21

16.31

4.31

315

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

173

2.27

5.39

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.55

5.32

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

491

1.73

5.30

1.3

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

1342

0.59

5.16

1.2

1.3

163.65

230.06

u/ml

0.97

1232

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.73

5.10

1.1

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.85

5.08

2.0

2.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

153

2.30

5.02

1.7

1.6

5782.76

1470.76

u/l

0.32

(3041096) Erythrocytes [Presence] in Urine by Automated

778

6687

1.21

5.01

3.6

3.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

345

1.84

4.96

1.9

1.2

—

(3035880) pH of Pleural fluid

129

2.42

4.96

1.2

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

338

1.85

4.95

1.7

1.3

0.59

0.66

nmol/l

0.75

324

(3028026) IgM [Mass/volume] in Serum or Plasma

180

1275

1.43

4.94

1.7

1.4

1.03

1.15

g/l

0.82

164

1140

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

696

0.45

4.93

1.5

1.7

5.83

4.24

mg/l

0.27

506

(3045142) Bone marrow Pathology biopsy report

181

2.17

4.87

1.3

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

315

4001

0.77

4.79

13.6

7.6

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

6.49

4.77

1.1

1.2

22.50

14.89

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.65

4.65

1.1

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

232

2.00

4.64

2.3

3.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1868

20004

0.86

4.63

3.6

4.2

17.78

13.09

mm/h

22.54

1706

18261

(3037467) Urinalysis macro (dipstick) panel - Urine

1995

18621

1.16

4.62

4.2

4.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.62

4.55

1.1

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

342

1.80

4.49

1.2

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

131

896

1.48

4.35

2.5

2.9

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

7.52

4.35

1.0

1.1

—

35.65

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

339

1.78

4.32

1.7

1.3

0.16

0.37

nmol/l

—

(3008898) HLA-B27 [Presence]

588

0.46

4.23

1.0

1.1

—

(1616796) Gas panel - Central venous blood

619

1.57

4.21

3.3

3.9

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

4.13

4.20

1.1

1.3

24.22

1161.90

u/l

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

290

2275

1.30

4.20

1.5

—

(3000330) Specific gravity of Urine by Test strip

210

1577

1.35

4.13

3.9

3.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

780

0.53

4.11

1.6

1.5

23839.48

13604.38

e6/l

0.41

570

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

278

2176

1.30

4.10

4.9

2.4

69.63

61.57

ml/min/173m2

2.18

133

863

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

868

0.56

4.08

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

210

1.96

4.01

1.1

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

784

0.54

3.97

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

184

2451

0.74

3.95

1.4

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

125

866

1.46

3.93

1.8

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.89

3.89

1.8

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

116

794

1.48

3.88

4.4

3.5

—

(3000492) Spirometry study

165

2226

0.73

3.85

1.4

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

478

0.44

3.73

1.2

1.3

—

(3008295) Osmolality of Serum or Plasma

253

1.83

3.66

1.4

275.81

276.33

mosm/kgh2o

0.06

188

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

5.64

3.65

1.2

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

5.64

3.65

1.2

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

5.64

3.65

1.2

1.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1175

12859

0.87

3.62

2.6

2.4

—

(3021788) Differential panel - Synovial fluid

546

0.49

3.50

1.8

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.37

3.48

2.3

2.7

—

(4200892) Spirometry reversibility

155

2072

0.74

3.44

1.3

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

4.08

3.39

1.3

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

495

0.48

3.31

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

583

1.50

3.28

1.3

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

316

1.69

3.25

1.1

1.2

252.12

272.73

u/ml

0.23

193

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2.39

3.22

2.0

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

442

1.57

3.19

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

817

0.61

3.14

3.1

3.2

0.74

0.83

nmol/l

1.75

631

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

337

1.64

3.06

1.1

1.2

—

(21494755) Public health laboratory ask at order entry panel

1170

0.68

3.04

1.2

1.4

—

(1002224) Polysomnography panel

747

0.60

3.03

1.0

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

504

0.51

3.01

1.1

1.2

18.20

22.86

u/l

0.40

437

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.85

2.97

1.2

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

256

1.73

2.97

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

2.95

0.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

2.95

0.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

2.95

0.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

2.95

0.0

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

948

0.65

2.94

1.2

0.40

0.78

u/ml

—

101

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

525

0.53

2.93

1.4

1.3

58.13

30.47

e6/l

0.34

414

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.25

2.93

2.1

2.6

—

(3003181) Sodium [Moles/volume] in Urine

525

1.50

2.92

1.3

66.87

62.22

mmol/l

0.41

416

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

229

1.76

2.86

1.1

1.3

—

(3017569) Oxygen content in Arterial blood

178

1.86

2.86

4.2

1.7

—

(3016750) Collection duration of Urine

171

1.88

2.85

1.9

446.14

490.58

min

0.95

123

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

796

0.62

2.85

1.3

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

595

1.46

2.82

1.9

2.6

1.50

1.75

mg/l

2.45

521

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

238

0.38

2.77

1.0

1.1

—

1.40

—

(3028717) Thiamine [Mass/volume] in Blood

3.92

2.77

1.1

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

268

3246

0.81

2.76

1.3

523.27

544.21

titre

0.05

737

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

516

1.48

2.75

1.2

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

585

6603

0.86

2.69

1.8

1178.97

1159.60

nmol/l

0.20

461

4918

(3040151) Glucose [Moles/volume] in Capillary blood

366

1.57

2.67

7.9

27.6

8.43

7.61

mmol/l

0.87

298

(3038026) Centromere Ab [Units/volume] in Serum

230

0.39

2.66

1.0

1.2

—

65.62

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1188

12805

0.89

2.66

2.1

90.39

93.71

pmol/l

1.57

728

6538

(3051611) Lipemic interference index of Serum or Plasma

265

1.67

2.66

5.0

3.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

553

1.46

2.66

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1275

0.71

2.63

1.2

218.37

122.57

iu/ml

0.91

474

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.39

2.63

1.1

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

790

0.64

2.61

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.61

2.57

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

7.15

2.55

1.0

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

225

0.40

2.54

1.0

1.2

—

87.78

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

225

0.40

2.54

1.0

1.1

—

27.84

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

227

0.39

2.54

1.0

1.2

—

49.95

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.98

2.48

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

520

1.45

2.47

1.4

1.6

—

(3004775) Volume in Urine collected for unspecified duration

263

1.64

2.47

2.1

2.3

748.04

624.00

0.58

165

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.82

2.46

1.8

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

218

1.70

2.44

1.7

2.8

66.25

59.50

1.18

173

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.13

2.43

1.7

2.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.13

2.43

1.8

2.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.13

2.43

1.1

1.3

—

(3044941) Cell count panel - Synovial fluid

506

0.57

2.42

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

229

1877

1.24

2.41

3.3

3.6

5.03

5.19

kpa

1.92

215

1756

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

2.21

2.37

2.5

2.2

40.22

45.38

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.64

2.36

1.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.64

2.36

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.61

2.35

2.0

2.3

—

(3042631) Mycobacterium sp identified in Specimen

346

1.54

2.35

2.2

3.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

176

1.77

2.33

1.2

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

248

0.40

2.31

1.0

215.40

338.53

ng/l

—

156

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

155

1.81

2.29

1.1

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

171

1.76

2.24

1.2

1.3

—

(3009343) pH of Capillary blood

224

1850

1.22

2.22

3.3

3.6

7.42

0.42

218

(3029937) Albumin [Presence] in Urine by Test strip

801

7315

1.12

2.18

3.8

4.3

0.00

estimate

0.50

276

2141

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1263

11822

1.11

2.18

3.9

4.1

34.57

88.49

ng/l

2.38

1026

8926

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

362

0.52

2.17

1.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.24

2.17

1.1

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.24

2.17

1.1

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

122

1.89

2.15

1.7

1.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

2.62

2.14

1.8

1.6

26.04

54.79

u/l

0.34

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1098

10218

1.11

2.11

4.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.20

2.09

1.3

1.0

—

(3004451) EKG impression Narrative

160

1.76

2.09

1.1

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

208

0.43

2.06

1.0

1.2

—

6.00

—

(3007853) Bacteria identified in Skin by Aerobe culture

358

3108

1.17

2.06

1.8

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1119

10438

1.10

2.05

2.6

2.8

215.64

138.17

ug/l

9.45

1041

9443

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

191

0.42

2.04

1.0

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

215

1787

1.22

2.02

3.3

3.5

2.25

1.90

mmol/l

0.46

148

1302

(3027945) Reticulocytes/100 erythrocytes in Blood

392

3437

1.16

1.99

2.2

2.0

1.91

1.76

1.32

365

2974

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

178

1.69

1.98

1.2

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

230

0.43

1.97

1.0

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

716

0.68

1.96

1.7

1.6

17.39

4.38

iu/ml

0.34

166

(3009261) Glucose [Presence] in Urine by Test strip

1413

13354

1.10

1.95

3.8

3.9

0.00

estimate

1.08

290

2134

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.94

1.95

1.0

1.8

48.57

150.54

umol/l

—

(3021601) Nitrite [Presence] in Urine by Test strip

1395

13186

1.09

1.91

5.1

0.00

estimate

-0.00

310

2219

(3024263) Appearance of Synovial fluid

173

0.40

1.90

1.0

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.19

1.88

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

2.16

1.88

1.2

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.09

1.86

1.1

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.98

1.84

1.6

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.98

1.84

1.6

2.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.58

1.80

1.7

1.5

—

(3012516) Albumin [Mass/volume] in Urine

885

9515

0.91

1.77

2.9

3.2

365.61

250.62

mg/l

0.37

587

6094

(40768443) Skin Pathology biopsy report

1033

0.75

1.76

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

207

1744

1.20

1.73

1.2

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1086

0.76

1.73

1.4

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

742

1.30

1.72

1.3

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

334

0.57

1.72

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

458

4105

1.13

1.71

1.5

1.3

2.61

2.68

g/l

0.33

279

2277

(3023410) Appearance of Cerebral spinal fluid

214

0.47

1.67

1.1

1.5

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

3.16

1.66

4.2

109.50

51.69

ug/min

—

(42529406) Shigella sp [Presence] in Stool by Culture

747

1.29

1.65

1.3

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

213

0.47

1.65

1.1

—

(3019225) pH of Specimen

325

2862

1.15

1.59

3.9

3.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

181

2143

0.84

1.57

2.0

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

1391

13234

1.08

1.57

3.8

3.9

0.01

0.00

estimate

0.21

333

2442

(3017732) Neutrophils [#/volume] in Blood

197

1671

1.19

1.56

4.9

3.1

5.58

5.67

e9/l

0.03

159

1221

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

160

1.63

1.55

1.3

1.2

16.57

10.69

u/l

0.67

139

(4034850) Laboratory test

1034

0.77

1.55

14.5

10.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

737

1.28

1.54

1.3

1.1

—

(3011985) Renin [Units/volume] in Plasma

340

1.42

1.52

1.5

1.3

38.43

63.95

mu/l

1.02

304

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

144

0.42

1.51

1.5

1.1

84.10

38.63

mg/l

—

123

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

0.00

1.49

0.0

1.9

—

9.20

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

307

0.58

1.49

1.3

25035.00

153579.91

e6/l

1.95

213

(3023420) DNA double strand Ab [Units/volume] in Serum

230

0.52

1.48

1.8

1.3

—

23.91

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

124

1.70

1.47

1.0

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

604

0.71

1.46

1.1

1.2

—

296.67

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

140

1.65

1.44

1.5

10.11

7.82

u/l

0.18

119

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.92

1.43

1.5

1705.21

69.96

nmol/24h

0.89

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

404

1.37

1.43

1.2

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.73

1.43

2.2

—

25.49

—

(3000494) Fungus identified in Specimen by Culture

332

2953

1.14

1.43

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

304

1.42

1.40

1.2

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

180

0.50

1.39

1.0

1.1

2.85

2.16

mmol/l

—

169

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

373

0.64

1.38

1.5

1.4

69.36

63.58

0.27

244

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

314

1.41

1.37

1.2

1.3

—

(3044889) 12 lead EKG panel

1874

19376

0.93

1.36

4.3

4.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

391

1.36

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

273

0.58

1.35

1.2

1.1

—

(3021901) Oxygen saturation in Capillary blood

558

1.30

1.33

3.4

2.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.00

1.32

0.0

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

649

0.74

1.32

1.7

1.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

308

1.40

1.32

1.2

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

683

1.27

1.32

2.1

116.02

130.60

g/l

5.78

504

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

283

0.60

1.31

1.4

19.36

27.94

—

187

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.85

1.29

1.2

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

2.78

1.28

3.4

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

2.78

1.28

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

231

0.56

1.28

1.0

1.4

—

(3000012) Reticulocyte production index

396

1.34

1.27

1.8

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

412

0.68

1.26

1.1

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

158

0.51

1.24

1.0

1.4

135.66

169.24

pmol/l

—

158

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

226

2566

0.87

1.21

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

156

1.54

1.20

2.5

2.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

299

1.38

1.16

1.2

1.3

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

248

0.60

1.15

1.0

1.4

—

181.33

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

128

1512

0.84

1.15

1.8

2.2

12.22

14.69

nmol/l

2.87

114

1320

(3047007) Chlamydophila sp Ab [Presence] in Serum

260

0.61

1.15

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

113

0.44

1.12

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

113

0.44

1.12

1.0

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

143

1.54

1.11

1.3

1.8

1.33

1.86

u/field

0.31

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.78

1.10

1.3

1.4

15.32

15.97

pmol/l

0.19

(3005988) Vibrio sp identified in Specimen by Organism specific culture

302

1.36

1.10

1.2

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.26

1.10

1.0

1.1

61.77

156.47

ng/l

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

182

0.55

1.10

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

160

1.50

1.09

1.5

1.4

12.83

14.42

u/l

0.75

153

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

252

1.39

1.08

2.0

2.1

1.08

1.68

u/field

0.55

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

128

1.57

1.08

1.1

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

302

0.66

1.06

1.7

2.1

1.98

1.48

g/24h

—

136

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

285

3157

0.89

1.05

2.3

2.5

3.80

7.14

ug/l

9.55

240

2704

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

522

0.74

1.05

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

281

1.36

1.02

1.2

409.83

339.52

nmol/l

0.85

227

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

110

0.45

1.00

1.0

1.9

21.52

330.06

ug/l

—

103

(3025018) Bordetella pertussis Ab [Titer] in Serum

110

0.45

1.00

1.0

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

300

1.34

0.98

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

1.71

0.98

1.5

1.8

—

(3015736) pH of Urine

1111

10638

1.06

0.98

3.5

3.6

5.72

5.79

0.24

443

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

2.0

—

19.37

—

(3045424) Erythrocytes [Presence] in Urine

435

0.73

0.97

1.6

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.95

0.97

1.3

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.96

0.0

3.8

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

257

2319

1.12

0.94

1.5

1.8

1.64

1.57

0.52

211

1958

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.78

0.94

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1007

0.83

0.93

1.6

1.8

38.81

38.26

u/l

0.08

835

(44813793) Dust mix specific IgE antibody measurement

142

0.56

0.93

1.0

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

220

0.63

0.91

2.2

2.3

—

(3044927) Protein electrophoresis panel - Urine

384

0.73

0.91

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

131

1135

1.16

0.90

3.4

4.0

24.58

24.80

mmol/l

0.28

118

1024

(3049717) Cytology report of Urine Cyto stain

111

949

1.18

0.90

2.7

1.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

104

0.48

0.89

1.0

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

105

0.48

0.88

1.2

1.3

71.08

59.94

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

329

3021

1.10

0.88

3.2

192.96

239.14

ng/l

1.39

304

2776

(3002619) Bacteria identified in Specimen by Culture

1.86

0.87

1.5

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

161

1.43

0.86

2.4

1.9

130.50

17.33

umol/l

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.82

0.85

1.0

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

927

9683

0.94

0.84

2.9

3.1

6.85

7.33

mmol/l

3.33

756

8059

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

479

0.77

0.83

1.1

1.4

—

(3014271) Vancomycin [Susceptibility]

197

1.37

0.82

2.8

3.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.65

0.81

3.4

1.8

0.83

1.27

ug/l

0.65

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

642

6775

0.94

0.81

1.7

464.40

31265207.76

pmol/l

4.96

519

5495

(3022145) Colonoscopy Study observation

278

2545

1.10

0.81

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

173

1.39

0.78

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.50

0.77

2.4

1.5

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.77

0.0

1.1

—

32.13

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

504

0.79

0.75

1.8

1.7

2.65

4.67

iu/l

1.84

162

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

271

1.29

0.74

1.1

—

(3020491) Glucose [Moles/volume] in Blood

210

1.34

0.73

2.2

2.5

7.06

6.90

mmol/l

0.15

139

(3014891) Appearance of Pleural fluid

1.84

0.73

1.1

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.64

0.73

1.6

1.0

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.00

0.72

1.2

1.1

—

(3022313) Gas panel - Capillary blood

150

1340

1.12

0.71

3.4

3.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

772

0.84

0.70

1.9

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

112

983

1.14

0.69

1.4

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2603

26387

0.95

0.69

35.0

14.3

38.47

24.90

mg/l

65.20

2471

20830

(3020682) Albumin/Creatinine [Ratio] in Urine

973

10093

0.95

0.69

3.4

3.8

10.52

8.67

mg/mmol

0.53

624

6380

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

178

1.35

0.68

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

179

1.34

0.66

4.4

2.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.59

0.65

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

872

0.86

0.65

1.9

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

120

1.42

0.64

1.1

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

120

1.42

0.64

1.1

1.2

—

(40765096) Chromosome analysis panel by Banding

1.73

0.64

1.0

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

128

0.62

0.64

6.5

5.3

—

65.21

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

101

0.59

0.62

1.2

1.1

—

(3019174) dRVVT (LA screen)

0.00

0.60

0.0

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.60

0.0

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.60

0.0

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

828

1.14

0.58

2.3

2.1

74.92

108.36

ug/min

0.60

484

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.0

—

0.99

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.51

0.58

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

309

1.23

0.58

2.6

3.0

17.41

31.20

mg/l

0.95

236

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

518

0.83

0.57

1.4

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

116

0.60

0.57

1.0

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

466

1.18

0.56

2.6

3.1

—

(3017704) Immunofixation for Urine

172

0.70

0.56

1.1

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

159

1.32

0.55

3.0

1.8

—

(3022621) pH of Urine by Test strip

205

1897

1.09

0.53

2.9

3.1

—

(3029075) Extractable nuclear Ab panel - Serum

1.45

0.53

1.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1078

11087

0.96

0.53

2.4

2.2

71.43

78.84

nmol/l

14.16

984

9609

(3051593) INR in Capillary blood by Coagulation assay

181

0.72

0.52

26.4

11.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.43

0.52

1.4

1.2

117.11

113.79

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

922

0.89

0.48

2.9

1.5

3.09

2.93

ratio

0.04

(3034860) Kappa light chains.free [Mass/volume] in Serum

952

0.89

0.47

2.9

1.5

48.95

47.21

mg/l

0.12

774

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

626

1.14

0.46

1.4

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

950

0.89

0.46

2.8

1.5

32.32

34.18

mg/l

0.22

767

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

120

1.33

0.46

1.1

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

586

5641

1.05

0.45

1.9

1.7

3.02

1.35

mg/l

5.69

489

4371

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.40

0.45

2.0

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

140

0.71

0.43

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.56

0.42

3.2

1.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.41

0.0

3.4

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.41

0.0

1.1

—

7.30

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.00

0.40

0.0

1.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.39

0.0

1.1

—

(3019150) Specific gravity of Urine by Refractometry

604

6239

0.96

0.38

4.0

4.3

1.02

kg/l

0.52

104

964

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.36

0.38

1.4

1.2

0.36

0.31

g/l

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

972

9950

0.97

0.37

2.8

3.2

1383.11

1726.12

ng/l

1.66

857

8560

(3002079) Sodium [Moles/time] in 24 hour Urine

107

1.31

0.37

1.3

1.2

152.43

170.81

mmol/24h

0.58

107

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.35

0.37

7.0

13.4

4.64

5.03

mmol/l

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

511

4934

1.04

0.37

1.2

3.39

1.79

u/ml

0.63

116

1258

(3023511) Choriogonadotropin [Units/volume] in Urine

1.27

0.36

1.6

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

271

2580

1.05

0.35

2.2

2.1

71.78

68.05

e9/l

0.64

211

1962

(21494434) Karyotype in Bone marrow

201

0.80

0.35

1.3

1.1

—

(3025130) Human papilloma virus identified in Specimen

144

1.25

0.35

1.6

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

320

1.16

0.34

1.3

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

104

1127

0.92

0.34

2.1

1.4

3.10

2.92

g/l

1.18

980

(3037121) Protein [Mass/volume] in Urine

901

1.09

0.34

2.4

2.5

0.24

0.33

g/l

0.72

306

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

949

0.91

0.33

2.3

1.4

37.07

37.62

g/l

0.37

802

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1000

0.92

0.33

2.3

1.5

0.82

0.44

g/l

0.96

849

(40768446) Kidney Pathology biopsy report

0.70

0.33

1.0

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

249

2609

0.95

0.31

1.8

2.1

117.83

168.64

ug/g

1.75

203

2033

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

112

1204

0.93

0.31

2.1

1.4

7.47

7.51

g/l

0.08

103

1056

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

112

1203

0.93

0.31

2.1

1.4

—

(36660697) Celiac disease serology panel - Serum

170

1795

0.94

0.29

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

109

0.73

0.29

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

701

0.91

0.28

2.8

1.5

—

(3027944) Amphetamines [Presence] in Urine

261

1.15

0.27

1.2

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

720

1.09

0.27

2.1

2.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.23

0.27

1.0

1.3

—

(40757373) Influenza virus identified in Isolate

1.19

0.26

1.3

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

478

0.90

0.26

1.4

—

(3037756) Immunofixation for Serum or Plasma

568

1.09

0.26

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

256

0.86

0.25

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

309

0.87

0.25

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.20

0.25

1.2

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

113

1199

0.94

0.24

2.1

1.4

3.66

3.75

g/l

0.34

104

1052

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

255

0.86

0.24

2.4

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

145

1377

1.06

0.24

1.5

1.66

1.53

g/l

0.91

126

1180

(3028433) Virus identified in Specimen by Culture

1.28

0.24

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

264

2738

0.96

0.24

1.3

—

(3027008) Opiates [Presence] in Urine

265

1.13

0.23

1.2

1.7

—

(3028300) Cannabinoids [Presence] in Urine

266

1.13

0.22

1.2

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

169

1616

1.05

0.22

2.7

2.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.77

0.22

1.4

1.1

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.21

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.7

—

(3045414) Leukocytes [Presence] in Urine

112

1181

0.95

0.21

1.9

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.16

0.21

1.4

1.8

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate

1.24

0.21

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.23

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.20

0.0

1.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

114

0.79

0.20

1.7

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

1.20

0.19

1.3

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

788

0.94

0.19

1.2

1.5

—

18.23

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

133

0.83

0.19

1.0

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

133

0.83

0.19

1.0

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

133

0.83

0.19

2.2

—

(3013512) EKG study

885

8720

1.02

0.19

4.4

4.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

203

1.13

0.19

1.2

1.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

107

1123

0.95

0.18

2.1

1.4

10.04

10.34

g/l

0.38

969

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.17

0.17

1.0

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

329

1.10

0.17

1.2

193.08

197.52

miu/ml

0.02

126

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

233

1.12

0.17

1.0

8.07

2.20

u/ml

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.15

0.17

9.9

7.0

—

(3000764) Benzodiazepines [Presence] in Urine

263

1.10

0.16

1.1

1.8

—

(3051101) Glucose [Moles/volume] in Cord blood

1.14

0.16

3.9

6.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.10

0.15

9.4

7.1

—

(3011288) Drugs identified in Urine by Screen method

168

1.13

0.15

1.1

2.7

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

0.79

0.15

1.0

1.1

82.50

92.71

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.11

0.15

9.0

7.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

129

0.85

0.14

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

150

1.13

0.14

3.5

4.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

120

1244

0.96

0.13

2.7

2.8

4.19

4.40

pmol/l

0.92

104

1062

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

284

0.91

0.13

3.1

3.7

—

(3023419) Bacteria identified in Sputum by Culture

468

0.94

0.12

1.9

2.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

251

2456

1.02

0.12

2.0

1.6

64.17

66.63

g/l

4.67

227

2154

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

322

0.93

0.11

1.1

1.2

2.92

5.96

u/ml

1.40

148

(4146454) Self-monitoring of blood glucose

362

0.94

0.10

2.8

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

177

0.90

0.10

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

177

0.90

0.10

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

177

0.90

0.10

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

662

6552

1.01

0.10

3.3

3.9

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.14

0.10

1.0

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.14

0.10

1.0

1.1

18.78

48.20

mg/l

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.06

0.09

1.2

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.07

0.08

1.2

1.4

—

(3020650) Glucose [Presence] in Urine

1.05

0.08

2.2

1.5

—

(3006462) Nitrate [Presence] in Urine

136

1.10

0.08

1.8

3.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

107

1.12

0.08

1.4

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

107

1.12

0.08

1.4

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.14

0.08

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

657

1.04

0.08

3.4

3.8

38.88

28.72

mg/l

1.33

439

(3000093) Morphology [Interpretation] in Blood Narrative

254

1.06

0.07

1.1

—

(3034426) Prothrombin time (PT)

0.84

0.07

1.2

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.81

0.07

2.7

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

174

0.92

0.07

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

174

0.92

0.07

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

174

0.92

0.07

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

276

0.94

0.07

2.1

1.2

—

(40761535) Cells panel - Urine sediment

255

2583

0.99

0.06

3.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

354

1.05

0.06

1.6

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

332

0.96

0.04

1.2

3.73

3.33

u/ml

0.06

100

(3020961) Endomysium IgA Ab [Titer] in Serum

956

0.98

0.04

1.1

437.00

271.92

titre

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

121

1.07

0.03

1.3

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

309

1.04

0.03

2.1

1.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

224

2259

0.99

0.03

3.6

80.93

97.75

ng/l

2.56

189

1878

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

590

1.02

0.02

1.0

1.1

7.77

u/ml

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

810

1.01

0.02

2.4

1.5

0.00

g/l

-0.00

737

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

889

0.99

0.01

2.3

1.5

0.08

0.03

g/l

0.42

803

(3003740) Influenza virus B Ag [Presence] in Specimen

203

1.03

0.01

1.2

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

176

0.97

0.00

1.2

1.9

78.94

94.60

umol/l

1.44

176

(3002523) Influenza virus A Ag [Presence] in Specimen

204

1.03

0.00

1.2

1.1

—

(3047189) Immunofixation for 24 hour Urine

108

1.02

0.00

2.5

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

125

1.04

0.00

1.2

1.4

1.57

1.55

g/l

0.08

125

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

135

0.96

0.00

1.6

2.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

825

1.01

0.00

2.4

1.5

0.02

0.00

g/l

0.49

740

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

104

1045

1.00

0.00

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

249

1.00

0.00

1.2

1.8

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

629

1.00

0.00

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

661

1.00

0.00

1.6

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

114

0.96

0.00

1.6

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

176

1.02

0.00

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

124

0.97

0.00

1.1

2.2

—

(3024471) HLA-A [Type]

0.85

0.00

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.98

0.00

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

0.00

-0.00

0.0

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.89

-0.00

1.0

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

-0.00

0.0

8.3

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

-0.00

0.0

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

0.94

-0.00

1.4

1.2

—

64.00

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

1.48

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3024932) HLA-DR beta [Type]

0.86

-0.00

1.2

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

5.60

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

121.40

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

-0.00

0.0

7.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.6

—

2.66

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

731

7310

1.00

-0.00

1.6

20.14

20.24

nmol/l

0.07

674

6126

(21491868) Cryoglobulin [Mass/volume] in Serum

0.91

-0.00

1.4

1.2

—

0.06

—

(3009871) Measles virus Ab [Titer] in Serum

0.88

-0.00

1.6

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

130

1.00

-0.00

1.1

1.2

133.15

143.46

nmol/l

0.87

130

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

4.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.34

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.91

-0.00

1.0

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.8

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.0

—

375.62

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.86

-0.00

1.0

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

-0.00

0.0

3.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.8

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.1

—

1.36

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1352.00

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_PANCREAS_WIDE – Malignant neoplasm of pancreas, including Hilmo

GWS hits: 3

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of pancreas, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of pancreas, including Hilmo (C3_PANCREAS_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints